Human insulin has been evaluated across numerous clinical trials spanning phase 1 through phase 4 protocols for glycemic and metabolic management. Sponsored by academic institutions and medical centers including Massachusetts General Hospital, Beth Israel Deaconess Medical Center, and the University of California San Francisco, these studies encompass type 2 diabetes mellitus, gestational diabetes, prediabetes, insulin-dependent diabetes, and peripheral vascular disease. Ranging in status from completed and recruiting to terminated, withdrawn, and not yet recruiting, these trials evaluate various therapeutic regimens and combination strategies.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07321028 | ENROLLING_BY_INVITATION | Cellular Injury and Post-Cryogenic Recovery; Cryogenic Cellular Stress; Cold-Induced Cellular Injury; Thermal Injury Response; Post-Thaw Viability Impairment; Osmotic Stress Injury; Biomechanical Injury Modeling (In-Vitro); Blunt Force Injuries to the Extremities (Cellular Injury Model); Tissue Damage and Recovery Pathways; Hypothermic Tissue Stress; Cellular Regeneration and Repair |
Truway Health, Inc. |
2025-12-10 | EARLY_PHASE1 |
| NCT04062890 | WITHDRAWN | Hyperinsulinism; Insulin Resistance; Insulin Sensitivity; Glucose Intolerance; Hypertension |
University of Arizona |
2030-04-15 | PHASE2 |
| NCT00117936 | NOT_YET_RECRUITING | Coronary Disease; Coronary Heart Disease; Myocardial Ischemia; Coronary Arteriosclerosis |
Venturis Therapeutics, Inc. |
2027-09-01 | PHASE2 |
| NCT07593859 | RECRUITING | Healthy Adult Participants |
Northeastern University |
2026-02-01 | |
| NCT07403604 | RECRUITING | Hyperinsulinemia; Insulin Resistance; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity |
Columbia University |
2026-07-01 | PHASE1 |
| NCT07659028 | NOT_YET_RECRUITING | Prediabetes; Obesity & Overweight; Inflamation; Oxidative Stress |
National and Kapodistrian University of Athens |
2026-07-01 | |
| NCT07639684 | NOT_YET_RECRUITING | Type 2 Diabetes Mellitus (T2D); Obesity (BMI>30) |
Boston Scientific Corporation |
2027-04 | |
| NCT07658352 | NOT_YET_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Shanghai Helioson Pharmaceutical Co., Ltd. |
2026-06-26 | PHASE1; PHASE2 |
| NCT06914128 | RECRUITING | MTAP-deleted Solid Tumors |
Bayer |
2025-03-21 | PHASE1; PHASE2 |
| NCT07675499 | RECRUITING | Type 2 Diabetes; Insulin Sensitivity/Resistance; Cognition; Brain Blood Flow |
Rutgers, The State University of New Jersey |
2026-08-03 | PHASE2; PHASE3 |
| NCT07321106 | RECRUITING | Colorectal Cancer; Colorectal Cancer (CRC); Colorectal (Colon or Rectal) Cancer; CRC; Metastatic Colon Cancer; Colon Cancer; Advanced Colorectal Cancer |
Cartography Biosciences |
2026-01-15 | PHASE1 |
| NCT06841913 | RECRUITING | Smoke Exposure; Influenza |
University of North Carolina, Chapel Hill |
2025-09-26 | PHASE4 |
| NCT01239550 | ACTIVE_NOT_RECRUITING | Diabetes; Obesity |
Vanderbilt University |
2011-04 | |
| NCT07775391 | RECRUITING | Premature Ovarian Insufficiency |
Shenzhen Wingor Biotechnology Co., Ltd. |
2026-08-03 | PHASE1; PHASE2 |
| NCT06956209 | RECRUITING | Underactive Bladder |
Iota Biosciences, Inc |
2025-09-24 | |
| NCT07418177 | NOT_YET_RECRUITING | AMD - Age-Related Macular Degeneration |
The First Affiliated Hospital with Nanjing Medical University |
2026-02-10 | PHASE1; PHASE2 |
| NCT05933707 | RECRUITING | Obesity; Insulin Resistance; Metabolically Healthy Obesity; Obesity, Metabolically Benign |
Washington University School of Medicine |
2023-06-14 | |
| NCT05912621 | RECRUITING | Obesity; Overweight and Obesity; Overweight |
Stanford University |
2023-11-09 | PHASE2 |
| NCT07515066 | NOT_YET_RECRUITING | Idiopathic Pulmonary Fibrosis (IPF) |
Huan Ye |
2026-05-01 | PHASE1 |
| NCT07756294 | NOT_YET_RECRUITING | Alzheimer Disease |
Wake Forest University Health Sciences |
2026-09 | PHASE2 |
| NCT07332455 | RECRUITING | Neoplasms, Prostate |
GlaxoSmithKline |
2026-02-10 | PHASE1; PHASE2 |
| NCT07180355 | RECRUITING | Friedreich's Ataxia (FA) |
Solid Biosciences Inc. |
2025-10-22 | PHASE1 |
| NCT06053814 | ACTIVE_NOT_RECRUITING | Duchenne Muscular Dystrophy |
NS Pharma, Inc. |
2024-09-18 | PHASE1; PHASE2 |
| NCT07628127 | RECRUITING | Obesity; Overweight |
Verdiva Bio Dev Limited |
2026-07-06 | PHASE1 |
| NCT07612891 | RECRUITING | Breast Cancer (Locally Advanced or Metastatic); Advanced Solid Cancers; Metastatic (Stage IV) Breast Cancer; Ovarian Cancer; Endometrial Cancer |
Shenzhen Ionova Life Sciences Co., Ltd. |
2025-07-04 | PHASE1; PHASE2 |
| NCT07222865 | WITHDRAWN | Brain Imaging |
Virginia Polytechnic Institute and State University |
2026-01 | |
| NCT05510830 | NOT_YET_RECRUITING | Human Papilloma Virus Infection; Human Papilloma Virus Integration; Cervical Intraepithelial Neoplasia; Cervical Cancer; Cervical Conization |
Tongji Hospital |
2022-10 | |
| NCT07460336 | NOT_YET_RECRUITING | Latent Autoimmune Diabetes in Adults (LADA) |
Second Xiangya Hospital of Central South University |
2026-05-15 | |
| NCT05989347 | RECRUITING | Breast Cancer; Hyperinsulinism; HER2-negative Breast Cancer |
Yale University |
2024-10-15 | PHASE1 |
| NCT07454915 | RECRUITING | Cervical Intraepithelial Neoplasia Grade 2/3; Human Papilloma Virus Infection Type 16 |
PapiVax Biotech, Inc. |
2026-04-01 | PHASE2 |
| NCT06872060 | NOT_YET_RECRUITING | Kidney Diseases |
Bispebjerg Hospital |
2026-06-01 | |
| NCT07649044 | NOT_YET_RECRUITING | Smoking Cessation |
The University of Hong Kong |
2026-06-27 | |
| NCT06544655 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors |
Bristol-Myers Squibb |
2024-10-10 | PHASE1 |
| NCT06148025 | RECRUITING | Vaccine Response Impaired |
South Australian Health and Medical Research Institute |
2023-11-23 | PHASE4 |
| NCT07555483 | RECRUITING | Alpha 1 Antitrypsin Deficiency |
Grifols Therapeutics LLC |
2026-05-05 | PHASE3 |
| NCT05621668 | ACTIVE_NOT_RECRUITING | Soft Tissue Sarcoma; Bone Sarcoma |
M.D. Anderson Cancer Center |
2023-09-08 | PHASE1 |
| NCT07041801 | RECRUITING | Systemic Lupus Erythematosus (SLE) |
Shenzhen Beike Bio-Technology Co., Ltd. |
2025-06-28 | PHASE1; PHASE2 |
| NCT07164313 | RECRUITING | Hepatocellular Carcinoma; Squamous Cell Non-Small Cell Lung Cancer; Germ Cell Tumor |
Zymeworks BC Inc. |
2025-10-21 | PHASE1 |
| NCT05696561 | RECRUITING | OAG - Open-Angle Glaucoma |
New World Medical, Inc. |
2025-09-09 | |
| NCT05969041 | RECRUITING | Epithelial Tumors, Malignant |
Myeloid Therapeutics |
2023-08-02 | PHASE1 |
| NCT05818683 | RECRUITING | Metastatic Castration-resistant Prostate Neoplasms; Metastatic Hormone-sensitive Prostate Cancer |
Janssen Research & Development, LLC |
2023-04-26 | PHASE1 |
| NCT07060690 | NOT_YET_RECRUITING | Depression Symptoms; Depression - Major Depressive Disorder; Depressive Disorder |
Francesc Colom, PsyD, PhD |
2026-01 | |
| NCT07048405 | RECRUITING | Brown Adipose Tissue; Cold Exposure; 18F-FDG PET/CT |
University of Edinburgh |
2025-05-01 | |
| NCT03821935 | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors Cancer |
AbbVie |
2019-02-21 | PHASE1 |
| NCT05332301 | RECRUITING | Healthy Nutrition |
Kirsten Bell |
2022-10-04 | |
| NCT07265323 | RECRUITING | Alzheimer s Disease; Alzheimer Blood Biomarkers; Insulin Sensitivity |
Pennington Biomedical Research Center |
2025-12 | |
| NCT06667687 | ACTIVE_NOT_RECRUITING | Non-Hodgkin's Lymphoma |
AbbVie |
2025-01-16 | PHASE1 |
| NCT05270213 | RECRUITING | Advanced Cancer |
Riboscience, LLC. |
2022-07-11 | PHASE1 |
| NCT07359625 | RECRUITING | Insulin Resistance; Obesity & Overweight; Energy Metabolism; Ketone Body Metabolism |
University of Aarhus |
2025-12-02 | |
| NCT06705322 | NOT_YET_RECRUITING | Human Papillomavirus (HPV) Infection; Cervical Cancer |
Fudan University |
2024-12-01 | PHASE2 |
| NCT05307939 | RECRUITING | HPV; Oropharynx Cancer; HPV-Related Carcinoma; HPV-Related Malignancy; HPV Positive Oropharyngeal Squamous Cell Carcinoma |
Memorial Sloan Kettering Cancer Center |
2022-03-24 | PHASE2 |
| NCT05988632 | RECRUITING | Alcohol Use Disorder |
Brown University |
2025-02-25 | PHASE1; PHASE2 |
| NCT05548205 | RECRUITING | Diabetes |
NYU Langone Health |
2024-12-16 | |
| NCT07150416 | NOT_YET_RECRUITING | Multiple Pulmonary Ground-Glass Nodules; Lung Neoplasms; Precancerous Conditions |
The First Affiliated Hospital of Guangzhou Medical University |
2025-10-01 | PHASE2 |
| NCT03463564 | RECRUITING | Type 1 Diabetes Mellitus |
University of Campania Luigi Vanvitelli |
2016-01 | PHASE4 |
| NCT04532489 | RECRUITING | Radiotracer; Hypertension; Cholesterol |
Benjamin Viglianti |
2021-01-18 | EARLY_PHASE1 |
| NCT06667544 | RECRUITING | KRAS G12D Mutation |
Ranok Therapeutics (Hangzhou) Co., Ltd. |
2024-11-08 | PHASE1; PHASE2 |
| NCT07254364 | RECRUITING | Insulin Response; Type 1 Diabetes (T1D) |
Texas A&M University |
2025-09-11 | |
| NCT06202261 | RECRUITING | Metastatic Breast Cancer; Recurrent Breast Cancer; Advanced Malignancies |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2023-04-13 | PHASE1; PHASE2 |
| NCT06063850 | RECRUITING | Mesial Temporal Lobe Epilepsy |
UniQure Biopharma B.V. |
2024-06-12 | PHASE1; PHASE2 |
| NCT07287943 | RECRUITING | Type 1 Diabetes; Gastroparesis Due to Diabetes Mellitus Type I |
Viral N. Shah |
2026-02-09 | |
| NCT07215312 | ACTIVE_NOT_RECRUITING | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2025-10-13 | PHASE2 |
| NCT06635447 | ACTIVE_NOT_RECRUITING | Breast Cancer |
AstraZeneca |
2024-09-26 | PHASE3 |
| NCT07525089 | ENROLLING_BY_INVITATION | VRE Colonization; CRE Colonization |
BioMe Inc. |
2026-03-23 | |
| NCT07171684 | RECRUITING | Diabetes in Pregnancy; Gestational Diabetes |
Rutgers, The State University of New Jersey |
2025-11-26 | |
| NCT07557979 | NOT_YET_RECRUITING | Obesity (BMI>30) |
Texas Tech University |
2026-05-15 | |
| NCT07149337 | NOT_YET_RECRUITING | Aging; Kidney Disease; Mineral Metabolism |
University of Zurich |
2025-09-30 | |
| NCT07655076 | RECRUITING | Type 1 Diabetes Mellitus; T1D; Type 1 Diabetes; T1DM |
ClinSurge Research |
2026-05-19 | EARLY_PHASE1 |
| NCT06251635 | RECRUITING | Insulin Resistance; Menstrual Cycle; Type 2 Diabetes; Antipsychotics |
Centre for Addiction and Mental Health |
2024-06-03 | |
| NCT07384052 | RECRUITING | Spinal Cord Injury |
HealthPartners Institute |
2026-02-20 | PHASE1 |
| NCT04101188 | RECRUITING | Cardiovascular Risk Factor |
University of Delaware |
2020-01-16 | |
| NCT07746206 | RECRUITING | Treatment of Stage III Periodontitis; Local Application of Insulin in Pockets |
Doaa Atta Aid |
2026-07-24 | EARLY_PHASE1 |
| NCT06137157 | COMPLETED | Netherton Syndrome |
Azitra Inc. |
2024-06-16 | PHASE1 |
| NCT04711915 | ACTIVE_NOT_RECRUITING | Major Depressive Disorder; Depression |
Yale University |
2021-03-17 | PHASE1 |
| NCT07180446 | ACTIVE_NOT_RECRUITING | Obesity &Amp; Overweight |
Texas Christian University |
2026-01-18 | |
| NCT06501196 | RECRUITING | Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Preleukemia; Myelodysplastic Syndromes; Refractory Acute Myeloid Leukemia |
BlossomHill Therapeutics |
2024-06-19 | PHASE1 |
| NCT07014735 | TERMINATED | Diabetes Type 2; Hyperglycaemia (Diabetic); QT Interval, Variation in; Torsades de Pointes |
Richmond Pharmacology Limited |
2023-04-13 | |
| NCT07118852 | COMPLETED | Human Milk |
University of Wisconsin, Madison |
2025-11-14 | |
| NCT06588257 | COMPLETED | HPV |
Fundación Huésped |
2024-10-09 | PHASE4 |
| NCT02745613 | COMPLETED | Insulin Sensitivity/Resistance |
University of Texas, El Paso |
2016-04 | |
| NCT07021690 | NOT_YET_RECRUITING | Type 1 Diabetes (T1D) |
Steno Diabetes Center Copenhagen |
2025-06-30 | |
| NCT06877208 | ACTIVE_NOT_RECRUITING | Cerebral Glucose Metabolism |
Nicolai Jacob Wewer Albrechtsen |
2025-03-18 | |
| NCT06939959 | COMPLETED | Dry Eye; Insulin Sensitivity |
Khyber Teaching Hospital |
2025-04-14 | PHASE4 |
| NCT07259564 | TERMINATED | Adult Growth Hormone Deficiency (AGHD) |
Changchun GeneScience Pharmaceutical Co., Ltd. |
2025-12-19 | PHASE2 |
| NCT07543627 | ACTIVE_NOT_RECRUITING | Nurse Training; Geriatric; Communication Skills; EMPATHY İN NURSİNG |
Gazi University |
2026-04-15 | |
| NCT07527078 | RECRUITING | Type 2 Diabetes (T2DM) |
Gan & Lee Pharmaceuticals. |
2026-04-07 | PHASE3 |
| NCT05945628 | ACTIVE_NOT_RECRUITING | Memory |
University of Chicago |
2023-01-16 | |
| NCT07691177 | COMPLETED | Type 2 Diabetes |
Humanis Saglık Anonim Sirketi |
2026-02-06 | PHASE1 |
| NCT05803421 | COMPLETED | Type 2 Diabetes; Obesity; Overweight or Obesity; Overweight; Cardiovascular Diseases; Chronic Kidney Disease |
Eli Lilly and Company |
2023-04-03 | PHASE3 |
| NCT06799741 | COMPLETED | DENV-3 Controlled Human Infection Model |
AbViro LLC |
2025-01-07 | PHASE2 |
| NCT07486557 | COMPLETED | Central Obesity; Insulin Resistance; Inflammation |
Beijing Sport University |
2025-06-01 | |
| NCT04803058 | TERMINATED | Kidney Transplantation |
ITB-Med LLC |
2022-12-14 | PHASE2 |
| NCT05698199 | COMPLETED | Glioblastoma |
Immunomic Therapeutics, Inc. |
2023-08-21 | PHASE1 |
| NCT06017362 | RECRUITING | Dry Eye; Glaucoma |
Barbara Burgos Blasco |
2023-02-08 | PHASE4 |
| NCT06767748 | ACTIVE_NOT_RECRUITING | Diabetes |
Gan & Lee Pharmaceuticals. |
2025-02-15 | PHASE3 |
| NCT06011772 | ACTIVE_NOT_RECRUITING | Colo-rectal Cancer |
Roswell Park Cancer Institute |
2023-12-18 | EARLY_PHASE1 |
| NCT06831929 | RECRUITING | HPV Vaccine |
University of California, Davis |
2025-02-28 | |
| NCT05600062 | ACTIVE_NOT_RECRUITING | Acute Respiratory Distress Syndrome |
Queen Mary University of London |
2023-03-21 | |
| NCT07784283 | COMPLETED | Human Papillomavirus Vaccination; Cervical Cancer Prevention |
Clinton Health Access Initiative Inc. |
2024-12-01 | |
| NCT06562361 | UNKNOWN | MASH; PSC; Fibrostenotic Crohn's Disease; Healthy Volunteers |
Antaros Medical |
2024-08 | EARLY_PHASE1 |
| NCT06731374 | RECRUITING | Pneumococcal Disease; Pneumococcal Carriage |
University of Oxford |
2025-02-24 | PHASE4 |
| NCT06126354 | WITHDRAWN | Insulin Resistance; Prediabetic State; Non-Alcoholic Fatty Liver Disease; Overweight and Obesity |
Columbia University |
2024-07-01 | PHASE1 |
| NCT07319221 | COMPLETED | Detecting Number of Root Canal of Human Mandibular Second Molar |
Future University in Egypt |
2024-11-29 | |
| NCT05424822 | ACTIVE_NOT_RECRUITING | Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Janssen Research & Development, LLC |
2022-08-18 | PHASE1 |
| NCT06238778 | COMPLETED | Diabetes Mellitus, Type 1 |
Diasome Pharmaceuticals |
2023-12-28 | PHASE2 |
| NCT06589128 | RECRUITING | Digital Eye Strain (DES) |
Universiti Sains Malaysia |
2024-10-01 | |
| NCT05203835 | COMPLETED | Lymphedema of Upper Arm |
Stanford University |
2022-07-27 | PHASE2 |
| NCT06601101 | RECRUITING | Keratoconus; Cornea Disease; Eye Diseases; Wound Heal |
University of Campinas, Brazil |
2024-08-01 | PHASE3 |
| NCT06156488 | COMPLETED | Sinus Floor Augmentation |
Universidad de Granada |
2023-09-04 | |
| NCT05634174 | ACTIVE_NOT_RECRUITING | Obesity, Prediabetes |
University of California, San Diego |
2023-08-01 | PHASE1 |
| NCT05997095 | ACTIVE_NOT_RECRUITING | Skeletal Muscle Atrophy |
University of Nottingham |
2023-05-22 | |
| NCT07344688 | COMPLETED | Healhty |
Universitas Padjadjaran |
2025-08-22 | |
| NCT07103083 | RECRUITING | Blood Glucose; Blood Insulin |
Ocean Spray Cranberries, Inc. |
2025-07-21 | |
| NCT05724134 | COMPLETED | Insulin Resistance; Prediabetic State; Hyperinsulinemia; Non-Alcoholic Fatty Liver Disease; Obesity |
Columbia University |
2023-08-29 | PHASE1 |
| NCT06331559 | TERMINATED | Advanced Solid Tumors |
Jiangsu Simcere Pharmaceutical Co., Ltd. |
2024-03-19 | PHASE1 |
| NCT04710043 | COMPLETED | Solid Tumor |
BioNTech SE |
2021-06-08 | PHASE1 |
| NCT06866379 | RECRUITING | Alcohol Use Disorder |
Anders Fink-Jensen, MD, DMSci |
2025-05-07 | |
| NCT06627517 | ACTIVE_NOT_RECRUITING | Type 1 Diabetes Mellitus; Sleep Quality |
Luna Diabetes |
2024-11-22 | |
| NCT06082440 | UNKNOWN | Osteoarthritis, Knee |
First Affiliated Hospital of Wannan Medical College |
2023-11-22 | EARLY_PHASE1 |
| NCT07461103 | COMPLETED | Pemphigus Vulgaris; Skin Erosion; Autoimmune Blistering Disease |
Alexandria University |
2024-06-22 | PHASE2 |
| NCT06074705 | TERMINATED | Advanced Solid Tumor |
Daiichi Sankyo Co., Ltd. |
2023-08-04 | PHASE1 |
| NCT06650644 | COMPLETED | Autism Spectrum Disorder |
Miae Oh |
2024-10-10 | |
| NCT06724900 | ACTIVE_NOT_RECRUITING | Wrinkles in Decolletage; Pigmentation; Décolleté Wrinkles |
Krystal Biotech, Inc. |
2024-11-20 | PHASE1; PHASE2 |
| NCT06525272 | UNKNOWN | Pleurisy |
Healthgen Biotechnology Corp. |
2024-07 | PHASE1 |
| NCT05983627 | NOT_YET_RECRUITING | Acute Respiratory Distress Syndrome |
Asia Cell Therapeutics (Shanghai) Co., Ltd. |
2023-08-30 | PHASE1 |
| NCT02647827 | RECRUITING | Polycystic Ovary Syndrome; Insulin Resistance; Hyperandrogenism |
Karolinska Institutet |
2015-12 | PHASE2 |
| NCT04523363 | Not yet recruiting | Prediabetes; Complicating Pregnancy |
Gianna Wilkie|University of Massachusetts Worcester |
2025-06-01 | Phase 4 |
| NCT07045636 | COMPLETED | Microbial Colonization; Peri-Implantitis |
Jamil awad shibli |
2025-05-11 | |
| NCT06340854 | COMPLETED | Diabetes, Type 2 |
Novo Nordisk A/S |
2024-04-19 | PHASE3 |
| NCT05813912 | COMPLETED | Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2023-09-22 | PHASE3 |
| NCT04193709 | COMPLETED | Urinary Bladder, Neurogenic; Blood Pressure; Autonomic Dysreflexia; Bowel Incontinence |
University of Louisville |
2021-01-04 | |
| NCT05232851 | ACTIVE_NOT_RECRUITING | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Human Papillomavirus-Related Carcinoma; Locally Advanced Oropharyngeal Carcinoma; Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8 |
Mayo Clinic |
2022-06-16 | PHASE1; PHASE2 |
| NCT05922033 | COMPLETED | Gestational Diabetes Mellitus; Pregnancy in Diabetic; Pregnancy, High Risk |
Ohio State University |
2023-10-19 | PHASE4 |
| NCT05984238 | COMPLETED | Diabetes Mellitus, Type 2 |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2023-08-03 | |
| NCT06729203 | RECRUITING | Central Obesity |
Cairo University |
2024-12-01 | |
| NCT06435936 | ACTIVE_NOT_RECRUITING | PHA1A |
SAb Biotherapeutics, Inc. |
2024-04-22 | PHASE1 |
| NCT06765655 | ENROLLING_BY_INVITATION | Surgical Site Infections; Stress Hyperglycemia |
St. Peter's Hospital, Albany, NY |
2024-04-09 | |
| NCT06345755 | COMPLETED | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
Vertex Pharmaceuticals Incorporated |
2024-04-17 | PHASE1 |
| NCT05238142 | COMPLETED | Type 2 Diabetes Treated With Insulin |
Medtronic MiniMed, Inc. |
2022-02-25 | |
| NCT04994912 | COMPLETED | Healthy |
Elixiron Immunotherapeutics (Hong Kong) Ltd. |
2021-10-01 | PHASE1 |
| NCT05555446 | SUSPENDED | Celiac Disease; Gluten Sensitivity; Non-celiac Gluten Sensitivity |
Milky Way Life Sciences LLC |
2022-09-22 | EARLY_PHASE1 |
| NCT04049149 | UNKNOWN | Type 2 Diabetes |
Chinese University of Hong Kong |
2020-01-14 | |
| NCT06404905 | RECRUITING | Advanced Solid Tumor |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
2024-01-24 | PHASE1 |
| NCT05275855 | COMPLETED | Healthy Volunteers |
Novartis Pharmaceuticals |
2022-04-29 | PHASE1 |
| NCT06467201 | COMPLETED | Healthy Postmenopausal Women |
Amneal Pharmaceuticals, LLC |
2024-06-03 | PHASE1 |
| NCT06021275 | UNKNOWN | Scars; Insulin |
Alexandria University |
2023-10-01 | |
| NCT05083546 | Not yet recruiting | Obesity|Aging |
University of California San Francisco |
2024-12-01 | Phase 1|Phase 2 |
| NCT05699408 | COMPLETED | Type 2 Diabetes |
Jiangsu HengRui Medicine Co., Ltd. |
2023-03-31 | PHASE3 |
| NCT05511415 | COMPLETED | Postpartum Hemorrhage |
Samuel Lunenfeld Research Institute, Mount Sinai Hospital |
2022-11-02 | |
| NCT03369223 | COMPLETED | Advanced Cancer |
Bristol-Myers Squibb |
2017-12-06 | PHASE1; PHASE2 |
| NCT06080048 | COMPLETED | Ulcerative Colitis |
Sorriso Pharmaceuticals, Inc. |
2023-10-24 | PHASE1 |
| NCT05291975 | COMPLETED | Neuropathy, Diabetic; Neuropathy;Peripheral; Neuropathy, Painful |
Erchonia Corporation |
2022-02-17 | |
| NCT05267899 | UNKNOWN | Advanced Solid Tumors |
Zhejiang Haichang Biotech Co., Ltd. |
2022-08-01 | PHASE1 |
| NCT06400082 | UNKNOWN | Wound Complication; Insulin Resistance, Diabetes |
Cairo University |
2023-04-16 | |
| NCT05653050 | COMPLETED | Type 1 Diabetes |
University of Cambridge |
2023-02-20 | |
| NCT06458946 | COMPLETED | Blood Glucose; Blood Insulin |
Ocean Spray Cranberries, Inc. |
2024-05-22 | |
| NCT05436223 | UNKNOWN | B-cell Non-Hodgkin's Lymphoma |
Hrain Biotechnology Co., Ltd. |
2021-08-09 | PHASE2 |
| NCT05456854 | WITHDRAWN | Metabolic Disease |
Massachusetts General Hospital |
2022-06-03 | PHASE1 |
| NCT05654805 | UNKNOWN | Type 2 Diabetes; NAFLD |
Charite University, Berlin, Germany |
2022-12-15 | |
| NCT06212804 | COMPLETED | Healthy Volunteers |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2023-11-21 | PHASE1 |
| NCT04779645 | ACTIVE_NOT_RECRUITING | Type 1 Diabetes |
University of California, San Diego |
2021-07-31 | PHASE2 |
| NCT05933525 | COMPLETED | Diarrhea; Travelers Diarrhea; Infectious Diarrhea |
Immuron Ltd. |
2023-05-29 | PHASE2 |
| NCT06090370 | COMPLETED | Silicosis |
Johns Hopkins University |
2024-01-24 | |
| NCT06449703 | UNKNOWN | Healthy |
Tonghua Dongbao Pharmaceutical Co.,Ltd |
2024-05-06 | PHASE1 |
| NCT06909370 | COMPLETED | Human Papilloma Virus (HPV) |
Saglik Bilimleri Universitesi |
2024-05-01 | |
| NCT05545800 | UNKNOWN | Type 2 Diabetes Mellitus |
Xiangya Hospital of Central South University |
2022-09-01 | PHASE3 |
| NCT05786521 | COMPLETED | Aging; Diabetes Mellitus, Type 2; PreDiabetes; Overweight and Obesity |
The University of Texas Health Science Center at San Antonio |
2023-04-01 | PHASE4 |
| NCT07453680 | COMPLETED | PCOS (Polycystic Ovary Syndrome) |
Mst.Sumyara Khatun |
2023-06-01 | |
| NCT05556837 | COMPLETED | Healthy |
Société des Produits Nestlé (SPN) |
2024-03-04 | |
| NCT05613036 | COMPLETED | Solid Tumors |
Boehringer Ingelheim |
2023-01-03 | PHASE1 |
| NCT05907395 | COMPLETED | Healthy Participants |
Pfizer |
2023-08-09 | PHASE1 |
| NCT04763759 | COMPLETED | Prosthetic Joint Infection |
Trellis Bioscience LLC |
2021-02-08 | PHASE1 |
| NCT03950778 | COMPLETED | Albumin Supplementation; Albumin Therapy; Sepsis |
University of Pecs |
2023-03-04 | EARLY_PHASE1 |
| NCT06369649 | COMPLETED | Injection Fear; Injection Site Coldness; Pain; Type 1 Diabetes Mellitus; Pediatric Disease; Nurse's Role |
Ankara Yildirim Beyazıt University |
2023-07-01 | |
| NCT05462756 | COMPLETED | Type 2 Diabetes; Type 2 Diabetes Treated With Insulin |
Eli Lilly and Company |
2022-08-11 | PHASE3 |
| NCT05628532 | COMPLETED | Diabetes Mellitus, Type 1 |
Diabeloop |
2023-02-03 | |
| NCT05686733 | COMPLETED | Aneurysms Saccular; Aneurysm, Ruptured; Aneurysm |
Galaxy Therapeutics INC |
2022-01-26 | |
| NCT06147583 | UNKNOWN | Diabetes Mellitus, Type I |
University of Padova |
2023-12 | |
| NCT06181721 | COMPLETED | Diabetes Mellitus |
Insulet Corporation |
2023-09-05 | |
| NCT05901883 | COMPLETED | Healthy |
Celsius Therapeutics, Inc. |
2023-06-20 | PHASE1 |
| NCT05755685 | UNKNOWN | Peritoneal Metastases; Colorectal Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-02-10 | PHASE2 |
| NCT05498597 | UNKNOWN | Advanced Solid Tumor; Advanced Cancer; Advanced Carcinoma; Ovarian Cancer; Ovarian Carcinoma; Ovarian Epithelial Cancer; Ovarian Endometrioid Adenocarcinoma; Endometrial Cancer; Endometrial Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Endometrioid Adenocarcinoma; Endometrial Clear Cell Adenocarcinoma; Lung Adenocarcinoma; Triple Negative Breast Cancer; Pancreatic Ductal Adenocarcinoma; Malignant Pleural Mesothelioma; Ovarian Clear Cell Carcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Mucinous Adenocarcinoma |
Multitude Therapeutics Inc. |
2023-01-25 | PHASE1 |
| NCT05365152 | UNKNOWN | Diabetes; Blood Sugar; High |
Sun Yat-sen University |
2022-04-01 | |
| NCT04129710 | UNKNOWN | Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2020-01-01 | PHASE2 |
| NCT04227496 | UNKNOWN | Healthy; Pain |
University College of Northern Denmark |
2020-01-13 | |
| NCT05714059 | COMPLETED | Type 1 Diabetes |
Medtronic MiniMed, Inc. |
2023-02-28 | |
| NCT04123054 | COMPLETED | Diabetes Mellitus; Diabetes Mellitus, Type 1 |
McGill University |
2020-03-05 | |
| NCT05954923 | COMPLETED | Healthy |
University Hospital, Gentofte, Copenhagen |
2023-09-05 | |
| NCT03845114 | COMPLETED | Type 1 Diabetes Mellitus |
Institut de Recherches Cliniques de Montreal |
2019-06-30 | |
| NCT03415061 | UNKNOWN | Delirium; Heart Diseases |
Hiroaki Sato, MD., PhD. |
2021-11-01 | |
| NCT03493542 | COMPLETED | Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ |
Merck Sharp & Dohme LLC |
2018-08-31 | PHASE3 |
| NCT05556967 | COMPLETED | Adherence, Patient |
University of Mississippi Medical Center |
2023-08-09 | PHASE3 |
| NCT03163511 | COMPLETED | Type 1 Diabetes Mellitus With Hypoglycemia |
ViaCyte |
2017-07-06 | PHASE1; PHASE2 |
| NCT05426096 | COMPLETED | Diabetes; Hyperglycemia |
Vanderbilt University Medical Center |
2022-10-05 | |
| NCT03739645 | TERMINATED | Fear Pain |
Johns Hopkins University |
2020-08-01 | |
| NCT04963413 | TERMINATED | Glioblastoma |
University of Florida |
2022-01-13 | PHASE1 |
| NCT05883943 | ACTIVE_NOT_RECRUITING | Venous Insufficiency of Leg |
MED Institute Inc. |
2023-04-24 | |
| NCT04614168 | COMPLETED | Type 1 Diabetes; Type 1 Diabetes Mellitus With Hypoglycemia; Hypoglycemia; Hypoglycemia Unawareness; Glucagon Deficiency; Insulin Hypoglycemia |
University of Edinburgh |
2021-07-26 | |
| NCT05032599 | TERMINATED | T-Cell Acute Lymphoblastic Leukemia |
Beijing Boren Hospital |
2021-09-14 | PHASE1 |
| NCT05676801 | UNKNOWN | Prosthesis and Implants; Surgical Site Infection; Prosthetic Joint Infection; Postoperative Wound Infection Deep Incisional Surgical Site |
University of Zurich |
2023-02-04 | EARLY_PHASE1 |
| NCT04053283 | COMPLETED | Metastatic Cancer; Epithelial Tumor |
Akamis Bio |
2020-01-23 | PHASE1 |
| NCT05767255 | UNKNOWN | Diabetes Mellitus, Type 2 Treated With Insulin |
Hospital Universitario San Ignacio |
2022-12-01 | PHASE3 |
| NCT05001815 | UNKNOWN | Type 2 Diabetes; Pregnancy in Diabetic |
Peking University Third Hospital |
2021-12-15 | |
| NCT04957173 | WITHDRAWN | Type 2 Diabetes Treated With Insulin |
Centre hospitalier de l'Université de Montréal (CHUM) |
2021-10-14 | |
| NCT07265245 | COMPLETED | Type 2 Diabetes |
Ministry of Health, Malaysia |
2023-01-01 | |
| NCT05701813 | UNKNOWN | Obesity; Prediabetic State; Dyslipidemias; Insulin Resistance |
Azienda Ospedaliera Universitaria Integrata Verona |
2023-02-01 | |
| NCT04927546 | UNKNOWN | Rheumatoid Arthritis |
University of Sao Paulo |
2021-08 | |
| NCT04457778 | COMPLETED | Metastatic Solid Tumors |
EMD Serono Research & Development Institute, Inc. |
2020-07-10 | PHASE1 |
| NCT05090111 | COMPLETED | NASH - Nonalcoholic Steatohepatitis |
Aligos Therapeutics |
2021-12-01 | PHASE1 |
| NCT06281470 | COMPLETED | Hyperkalemia |
Waterstone Pharmaceutical (Wuhan) Co., LTD. |
2023-02-13 | PHASE1 |
| NCT05801653 | COMPLETED | Healthy |
Lund University |
2023-03-08 | |
| NCT04675255 | COMPLETED | HIV I Infection; Adiposity |
Washington University School of Medicine |
2021-01-01 | |
| NCT05091684 | TERMINATED | Hematological Patients; Bleeding; Platelet Refractoriness |
Centre Hospitalier Universitaire de Saint Etienne |
2022-02-10 | PHASE2 |
| NCT05515614 | COMPLETED | Premature Birth; Breastmilk Collection; Postnatal Growth Restriction |
Loma Linda University |
2022-08-17 | |
| NCT06624943 | COMPLETED | Type 1 Diabetes (T1D) |
Life for a Child Program, Diabetes Australia |
2022-03-14 | PHASE4 |
| NCT04950101 | COMPLETED | Human Papilloma Virus |
Universitair Ziekenhuis Brussel |
2020-10-20 | |
| NCT04100200 | ACTIVE_NOT_RECRUITING | Overweight or Obesity; Healthy |
Clinical Nutrition Research Center, Illinois Institute of Technology |
2019-10-07 | |
| NCT04772729 | UNKNOWN | Diabetes type1; Diabetes Mellitus, Type 1 |
Medical University of Warsaw |
2021-03-01 | PHASE4 |
| NCT04338659 | COMPLETED | Advanced Malignant Tumors Lymphomas |
Innovent Biologics (Suzhou) Co. Ltd. |
2021-01-14 | PHASE1 |
| NCT04014166 | COMPLETED | Thrombocytopenia; Mesenchymal Stem Cells |
Institute of Hematology & Blood Diseases Hospital, China |
2019-11-21 | |
| NCT05541939 | COMPLETED | Postbariatric Hypoglycemia |
Vogenx, Inc. |
2022-09-13 | PHASE2 |
| NCT04162639 | WITHDRAWN | Burns |
Virginia Commonwealth University |
2021-02 | PHASE4 |
| NCT05578352 | UNKNOWN | Type 2 Diabetes Mellitus |
Nanjing First Hospital, Nanjing Medical University |
2022-08-05 | |
| NCT05539872 | COMPLETED | Pharmacokinetics; Pharmacodynamics |
Amphastar Pharmaceuticals, Inc. |
2022-08-22 | PHASE2; PHASE3 |
| NCT04853017 | COMPLETED | Minimal Residual Disease; KRAS G12D; KRAS G12R; NRAS G12D; NRAS G12R; Pancreatic Ductal Adenocarcinoma; Colorectal Cancer; Non-small Cell Lung Cancer; Ovarian Cancer; Cholangiocarcinoma; Bile Duct Cancer; Gallbladder Carcinoma |
Elicio Therapeutics |
2021-10-04 | PHASE1 |
| NCT04995978 | WITHDRAWN | Prostate Cancer; Insulin Resistance |
St. Louis University |
2021-12-01 | PHASE2 |
| NCT04829045 | COMPLETED | Diabetes Mellitus, Type 2; Acupuncture |
Universiti Putra Malaysia |
2021-05-27 | |
| NCT02703493 | COMPLETED | Cancer of the Oropharynx |
Northwell Health |
2010-03-01 | |
| NCT04880837 | COMPLETED | Human Papillomavirus-Related Carcinoma |
Ohio State University Comprehensive Cancer Center |
2022-04-27 | |
| NCT05566197 | UNKNOWN | Metabolic Syndrome; Diabetes; Hyperlipidemias |
Hasanuddin University |
2022-07-15 | |
| NCT05448417 | UNKNOWN | Non-invasive Ventilation; Healthy Subjects |
Guangzhou Institute of Respiratory Disease |
2022-07-15 | |
| NCT04403763 | TERMINATED | Presbyopia |
AbbVie |
2020-07-27 | PHASE1; PHASE2 |
| NCT04561882 | UNKNOWN | Atrial Septal Aneurysm |
China National Center for Cardiovascular Diseases |
2020-09-04 | |
| NCT02885909 | UNKNOWN | HYPERGLYCEMIA |
Taichung Veterans General Hospital |
2016-09 | PHASE4 |
| NCT04662866 | UNKNOWN | Impaired Glucose Tolerance; Insulin Sensitivity; Glucose Metabolism Disorders |
Oslo University Hospital |
2021-02-10 | PHASE2 |
| NCT04573296 | COMPLETED | Insulin Resistance; Prediabetic State; Diabetes Mellitus, Type 2; Obesity |
Vitadio s.r.o. |
2020-02-26 | |
| NCT04920825 | COMPLETED | Endocrine and Metabolic Secondary Hypertension |
Universiti Sains Malaysia |
2021-05-01 | |
| NCT04926623 | COMPLETED | Type 2 Diabetes Mellitus |
Daewoong Pharmaceutical Co. LTD. |
2021-06-17 | |
| NCT02341807 | COMPLETED | Choroideremia; CHM (Choroideremia) Gene Mutations |
Spark Therapeutics, Inc. |
2015-01-15 | PHASE1; PHASE2 |
| NCT03313752 | COMPLETED | Type2 Diabetes Mellitus; Stable Coronary Artery Disease |
Giaccari Andrea |
2017-12-01 | PHASE3 |
| NCT05033444 | COMPLETED | Traumatic Brain Injury (TBI) |
Odyssey Group International, Inc. |
2022-02-09 | PHASE1 |
| NCT05084079 | UNKNOWN | Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucose Metabolism Disorders; Metabolic Disease; Endocrine System Diseases |
Sun Yat-sen University |
2021-11 | PHASE4 |
| NCT05229445 | COMPLETED | Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 |
Welldoc |
2022-07-05 | |
| NCT05252338 | COMPLETED | Influenza |
CureVac |
2022-02-07 | PHASE1 |
| NCT04753580 | COMPLETED | Healthy Volunteers; Frail Volunteers |
University Hospital, Clermont-Ferrand |
2021-10-04 | |
| NCT01659307 | COMPLETED | Acute Lung Injury |
Belfast Health and Social Care Trust |
2012-09 | PHASE2 |
| NCT05184868 | COMPLETED | Diabetes Mellitus, Type 1 |
Arecor Limited |
2022-01-03 | PHASE1 |
| NCT03724747 | COMPLETED | Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Bayer |
2018-12-18 | PHASE1 |
| NCT06411743 | COMPLETED | Hepatic Ascites |
The First Hospital of Jilin University |
2021-09-07 | PHASE2 |
| NCT04714216 | COMPLETED | Diabetes Mellitus |
Emory University |
2021-06-29 | |
| NCT04696146 | COMPLETED | End Stage Renal Disease; Chronic Kidney Diseases |
Cedars-Sinai Medical Center |
2021-03-03 | PHASE1; PHASE2 |
| NCT03457701 | COMPLETED | Anaemia |
GlaxoSmithKline |
2019-07-30 | PHASE2 |
| NCT04588259 | COMPLETED | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2020-10-09 | PHASE3 |
| NCT05372016 | COMPLETED | HPV Infections; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; CIN1; CIN2; CIN3; VaIN1; VaIN2; VaIN3; Genital Wart; VIN 1; VIN 2; VIN 3; AIS |
Shanghai Bovax Biotechnology Co., Ltd. |
2020-09-19 | PHASE3 |
| NCT06517485 | COMPLETED | Platinum Resistant Ovarian Cancer; Non-Small Cell Adenocarcinoma |
Mersana Therapeutics |
2019-07-30 | PHASE1 |
| NCT03612973 | COMPLETED | Chronic Hepatitis c |
Assiut University |
2019-06-01 | |
| NCT04782895 | COMPLETED | Cervical Cancer; Condylomata Acuminata |
Xiamen University |
2021-03-14 | PHASE3 |
| NCT04663282 | COMPLETED | Type 2 Diabetes |
Jiangsu HengRui Medicine Co., Ltd. |
2021-02-04 | PHASE2 |
| NCT03788772 | COMPLETED | Sepsis; Acute Circulatory Failure |
Assistance Publique - Hôpitaux de Paris |
2019-07-15 | |
| NCT04357392 | UNKNOWN | Diabetes Mellitus, Type 2 |
chenfengling |
2020-05-20 | EARLY_PHASE1 |
| NCT05506540 | COMPLETED | Healthy |
EnnovaBio |
2021-02-17 | PHASE1 |
| NCT05249374 | COMPLETED | Hepatic Ascites |
Beijing Protgen Biotechnology Development Co., Ltd. |
2021-10-14 | PHASE1 |
| NCT03972722 | UNKNOWN | Cervical Cancer |
Guangzhou Gloria Biosciences Co., Ltd. |
2019-05-15 | PHASE2 |
| NCT05490017 | COMPLETED | Paroxysmal Nocturnal Hemoglobinuria |
Kira Pharmacenticals (US), LLC. |
2020-12-30 | PHASE1 |
| NCT05292300 | COMPLETED | Insulin Resistance; Obesity; PreDiabetes |
Marmara University |
2021-05-24 | |
| NCT05062785 | COMPLETED | Out-Of-Hospital Cardiac Arrest; Healthy |
Robert Silbergleit |
2021-10-04 | PHASE1 |
| NCT05628662 | COMPLETED | Type 1 Diabetes Mellitus Prone to Hypoglycemia |
Hospital Clinic of Barcelona |
2021-10-22 | |
| NCT07298304 | COMPLETED | Prediabetic State; Glucose Intolerance; Insulin Resistance; Obesity and Overweight |
Dr. Soetomo General Hospital |
2022-03-01 | |
| NCT05308615 | COMPLETED | COVID-19 |
Indonesia University |
2021-03-03 | |
| NCT03203694 | COMPLETED | Type 2 Diabetes Mellitus; Obesity |
University of Missouri-Columbia |
2017-12-04 | |
| NCT04414592 | UNKNOWN | Lumbar Disc Degeneration; Lumbar Disc Herniation |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2020-08 | |
| NCT04501744 | COMPLETED | Malignant Ascites; Cancer |
Wuhan YZY Biopharma Co., Ltd. |
2018-09-30 | PHASE1 |
| NCT06920589 | COMPLETED | Human Papilloma Virus (HPV) |
Hospital Univeristario Benemerita Universidad Autonoma de Puebla |
2021-12-01 | |
| NCT04813133 | COMPLETED | Diabetic Neuropathies |
Riphah International University |
2021-02-05 | |
| NCT04644003 | COMPLETED | Autism Spectrum Disorder |
Stalicla SA |
2020-12-07 | PHASE1 |
| NCT03972982 | UNKNOWN | Newly Diagnosed Type 2 Diabetes; Simplified Short-term Intensive Insulin Therapy; Glycemic Remission |
Sun Yat-sen University |
2019-06-01 | PHASE4 |
| NCT04852029 | TERMINATED | Infertility, Female |
Reproductive Medicine Associates of New Jersey |
2021-08-16 | |
| NCT04553380 | UNKNOWN | Type 2 Diabetes |
Shenzhen Second People's Hospital |
2020-12-01 | |
| NCT04670302 | UNKNOWN | Supraspinatus Tear |
Dr. Soetomo General Hospital |
2019-10-17 | |
| NCT04341935 | WITHDRAWN | Coronavirus Infection; Type 2 Diabetes |
University of Miami |
2021-06-30 | PHASE4 |
| NCT04551443 | UNKNOWN | Acute Myocardial Infarction |
Navy General Hospital, Beijing |
2020-11-01 | PHASE2 |
| NCT04893148 | UNKNOWN | Type 2 Diabetes Mellitus; Glucose, High Blood |
Chungbuk National University Hospital |
2020-05-26 | PHASE4 |
| NCT04351672 | COMPLETED | Overweight and Obesity |
German Institute of Human Nutrition |
2020-06-23 | |
| NCT03489109 | TERMINATED | Human Immunodeficiency Virus; Metabolic Syndrome |
National Institute of Allergy and Infectious Diseases (NIAID) |
2018-05-09 | |
| NCT04690426 | COMPLETED | Viral; Infection, Coxsackie(Virus) |
Provention Bio, Inc. |
2020-12-14 | PHASE1 |
| NCT02947191 | UNKNOWN | Chronic Nasal Septum Perforation |
Chinese Academy of Sciences |
2016-11 | PHASE1; PHASE2 |
| NCT04517201 | UNKNOWN | Type 2 Diabetes |
Shanghai Zhongshan Hospital |
2020-11-04 | |
| NCT03477162 | TERMINATED | Thoracic Neoplasm |
Dartmouth-Hitchcock Medical Center |
2018-05-15 | EARLY_PHASE1 |
| NCT03989882 | COMPLETED | Overweight; Insulin Resistance; Inflammation |
Oklahoma State University |
2019-05-28 | |
| NCT04557098 | ACTIVE_NOT_RECRUITING | Hematological Malignancies |
Janssen Research & Development, LLC |
2020-09-17 | PHASE2 |
| NCT05040113 | COMPLETED | Healthy Adult Subjects |
Connect Biopharm LLC |
2021-09-04 | PHASE1 |
| NCT03720457 | UNKNOWN | CD19-positive; Diffuse Large B-cell Lymphoma; Follicular Lymphoma |
Hrain Biotechnology Co., Ltd. |
2018-11-13 | PHASE1 |
| NCT04123886 | COMPLETED | Malignant Pleural Effusion |
Sichuan Clover Biopharmaceuticals, Inc. |
2020-01-08 | PHASE1 |
| NCT04414631 | TERMINATED | Coronavirus Infections |
University Hospital, Basel, Switzerland |
2020-08-06 | PHASE2 |
| NCT05514080 | COMPLETED | Diabetes Mellitus, Type 2 |
McGill University |
2019-12-06 | |
| NCT05536934 | COMPLETED | Obese; Endothelial Function |
Karolinska Institutet |
2016-12 | EARLY_PHASE1 |
| NCT03284723 | TERMINATED | Breast Neoplasms |
Pfizer |
2017-11-01 | PHASE1 |
| NCT04877210 | UNKNOWN | Dry Eye |
Universiti Kebangsaan Malaysia Medical Centre |
2020-10-22 | PHASE1 |
| NCT04375046 | UNKNOWN | COVID-19 |
Kafrelsheikh University |
2021-07 | PHASE1 |
| NCT04018365 | UNKNOWN | Insulin Resistance - Type A; Insulin Resistance - Type B; Lipoatrophic Diabetes Mellitus; Insulin Resistance Syndrome |
Kobe University |
2019-09-01 | PHASE3 |
| NCT04501796 | TERMINATED | COVID-19 |
NeoImmuneTech |
2020-11-27 | PHASE1 |
| NCT05166941 | COMPLETED | Psychiatric Nursing |
Ankara Yildirim Beyazıt University |
2021-05-27 | |
| NCT06517433 | COMPLETED | Platinum Resistant Ovarian Cancer; Non Small Cell Lung Cancer Metastatic |
Mersana Therapeutics |
2017-12-12 | PHASE1 |
| NCT03866512 | COMPLETED | Healthy |
University of Exeter |
2019-05-10 | |
| NCT04914559 | COMPLETED | Diabetes Mellitus, Type 2 |
Société des Produits Nestlé (SPN) |
2021-05-17 | |
| NCT03422666 | COMPLETED | Hyperlipidemias |
University Health Network, Toronto |
2018-09-21 | PHASE2; PHASE3 |
| NCT02982772 | COMPLETED | Smoking Cessation; HIV |
dr. maria miguez |
2016-05 | |
| NCT04940910 | UNKNOWN | Immunity |
Chonbuk National University Hospital |
2021-02-22 | |
| NCT04898881 | COMPLETED | Pain |
Wayne State University |
2020-01-01 | PHASE4 |
| NCT01833559 | UNKNOWN | Gestational Diabetes |
First Affiliated Hospital, Sun Yat-Sen University |
2012-06 | |
| NCT04781751 | UNKNOWN | Pain, Neuropathic |
Minia University |
2021-02-28 | |
| NCT04298515 | UNKNOWN | Type 2 Diabetes; Insulin Resistance; Obesity; Nesfatin-1 |
Istanbul Medeniyet University |
2020-03-02 | |
| NCT06812351 | COMPLETED | Randomized Clinical Trial |
Ain Shams University |
2020-03-22 | PHASE1 |
| NCT03877068 | COMPLETED | Diabetes Mellitus |
Emory University |
2019-06-26 | |
| NCT04326868 | COMPLETED | Helminths Infection; Drug Resistance |
Centre de Recherche Médicale de Lambaréné |
2019-11-11 | PHASE4 |
| NCT02745808 | UNKNOWN | Erectile Dysfunction; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus |
Chinese Academy of Sciences |
2015-09 | PHASE1 |
| NCT03313830 | COMPLETED | Healthy |
The University of Texas Medical Branch, Galveston |
2017-10-07 | |
| NCT04501107 | COMPLETED | Type 1 Diabetes |
Adocia |
2020-08-03 | PHASE1 |
| NCT04564144 | UNKNOWN | Emesis |
Mansoura University |
2020-06-01 | PHASE1; PHASE2 |
| NCT03746938 | UNKNOWN | Heart Failure With Reduced Ejection Fraction |
Viscofan |
2018-11-13 | PHASE1 |
| NCT03607942 | COMPLETED | Premature Infant |
Société des Produits Nestlé (SPN) |
2018-08-06 | |
| NCT03767543 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2019-03-11 | PHASE3 |
| NCT04049123 | COMPLETED | Healthy |
Eli Lilly and Company |
2019-11-18 | PHASE1 |
| NCT03409107 | COMPLETED | Anaemia |
GlaxoSmithKline |
2018-03-05 | PHASE3 |
| NCT03947320 | UNKNOWN | Hemophilia A |
Sinocelltech Ltd. |
2019-12-20 | PHASE3 |
| NCT03526536 | TERMINATED | End-Stage Renal Disease; Diabetes Mellitus |
State University of New York - Downstate Medical Center |
2018-05-01 | PHASE4 |
| NCT03439917 | COMPLETED | Non-Alcoholic Fatty Liver Disease; Insulin Resistance |
University of Nottingham |
2018-04-02 | |
| NCT04276207 | COMPLETED | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2020-02-25 | PHASE1 |
| NCT04014192 | UNKNOWN | Type 2 Diabetes Mellitus |
Peking Union Medical College Hospital |
2019-09-01 | PHASE4 |
| NCT03829709 | COMPLETED | HTLV-I Infections |
Universidade Metodista de Piracicaba |
2019-01-30 | |
| NCT03324776 | COMPLETED | Type2 Diabetes |
Model Clinical Research LLC |
2017-10-16 | PHASE3 |
| NCT02824718 | COMPLETED | Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment |
Assistance Publique - Hôpitaux de Paris |
2017-06-06 | PHASE2 |
| NCT03970109 | TERMINATED | Alcohol Use Disorder |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2019-10-08 | PHASE2 |
| NCT04028960 | TERMINATED | Type1diabetes |
HealthPartners Institute |
2019-10-23 | PHASE2 |
| NCT04055246 | COMPLETED | Prebiotics and Human Behavior and Cognition |
Duke University |
2019-06-04 | |
| NCT03469492 | COMPLETED | Hyperglycaemia (Diabetic) |
Yale University |
2018-01-18 | EARLY_PHASE1 |
| NCT04097938 | COMPLETED | Healthy |
Lakefront Biotherapeutics NV |
2019-09-18 | PHASE1 |
| NCT05246748 | COMPLETED | Breastfeeding Education |
Gamze Durmazoğlu |
2019-01-01 | |
| NCT04011319 | UNKNOWN | Embryo Quality |
Tang-Du Hospital |
2019-04-01 | |
| NCT03994276 | COMPLETED | Postprandial Period |
King's College London |
2019-06-25 | |
| NCT04022291 | COMPLETED | Healthy Volunteer |
Biocon Limited |
2019-06-15 | PHASE1 |
| NCT03775902 | COMPLETED | Insulin Resistance |
University of Copenhagen |
2018-12-19 | |
| NCT04086173 | UNKNOWN | Obesity; Insulin Resistance; Microbial Colonization |
Hospital General de México Dr. Eduardo Liceaga |
2018-03-01 | |
| NCT03780582 | UNKNOWN | Lung Cancer |
Ensemble Group Holdings, LLC |
2018-12-14 | |
| NCT02385123 | TERMINATED | Influenza; Influenza Immunisation |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-04-01 | PHASE4 |
| NCT03291821 | COMPLETED | Infertility, Female |
IVI Madrid |
2017-12-01 | |
| NCT02302326 | COMPLETED | Polycystic Ovary Syndrome |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2013-01 | |
| NCT04093128 | UNKNOWN | Diet, Healthy |
Dr.Ruba Musharbash |
2019-06-01 | |
| NCT04007159 | COMPLETED | Skin Care |
GlaxoSmithKline |
2019-08-30 | |
| NCT03982238 | COMPLETED | Type 2 Diabetes |
Majianhua |
2019-06-15 | PHASE4 |
| NCT03658655 | COMPLETED | Type2 Diabetes |
CAR-T (Shanghai) Biotechnology Co., Ltd. |
2018-06-01 | EARLY_PHASE1 |
| NCT03490942 | TERMINATED | Hypoglycemia Unawareness; Diabetes Mellitus, Type 1 |
Xeris Pharmaceuticals |
2018-03-15 | PHASE2 |
| NCT03439488 | COMPLETED | Chronic Hepatitis B |
Alios Biopharma Inc. |
2018-03-26 | PHASE1 |
| NCT04075175 | COMPLETED | Diphtheria |
MassBiologics |
2019-04-23 | PHASE1 |
| NCT03726125 | COMPLETED | Healthy |
Eli Lilly and Company |
2018-11-20 | PHASE1 |
| NCT03796910 | COMPLETED | Healthy Volunteers |
Spero Therapeutics |
2018-12-18 | PHASE1 |
| NCT02232165 | TERMINATED | Acute Spinal Cord Injury |
University of Calgary |
2013-02 | |
| NCT03979690 | COMPLETED | Colonic Polyp; Colon Adenoma; Colorectal Cancer |
Bio-Medical Engineering (HK) Limited |
2019-06-12 | |
| NCT03794180 | COMPLETED | Healthy Adult Subjects |
I-Mab Biopharma US Limited |
2019-03-18 | PHASE1 |
| NCT04071574 | COMPLETED | Female Infertility; Female Infertility Due to Ovulatory Disorder; Premature Ovarian Failure; Polycystic Ovary Syndrome; Female Infertility of Tubal Origin; Ectopic Pregnancy; Salpingitis; Female Infertility Due to Tubal Block; Female Infertility Due to Tubal Occlusion; Hydrosalpinx; Female Infertility - Cervical/Vaginal; Female Infertility Endocrine; Endometriosis; Fibroids; Congenital Uterine Anomaly; Infections Uterine; Female Infertility of Other Origin |
Lebanese University |
2018-02-01 | PHASE1; PHASE2 |
| NCT03707990 | COMPLETED | Obesity and Overweight |
Novo Nordisk A/S |
2018-10-15 | PHASE1 |
| NCT03785808 | TERMINATED | Diet Modification; Lung Cancer |
Fred Hutchinson Cancer Center |
2018-12-21 | |
| NCT03651531 | TERMINATED | Gestational Diabetes |
Women and Infants Hospital of Rhode Island |
2018-01-03 | PHASE3 |
| NCT03361605 | COMPLETED | Healthy |
University of Michigan |
2017-04-12 | PHASE4 |
| NCT04235439 | COMPLETED | Diabetes Mellitus |
Gan and Lee Pharmaceuticals, USA |
2019-04-23 | PHASE1 |
| NCT02372175 | COMPLETED | Dengue |
U.S. Army Medical Research and Development Command |
2015-10 | PHASE1 |
| NCT03667053 | COMPLETED | Hypoglycemia |
Zealand Pharma |
2018-09-28 | PHASE3 |
| NCT03172494 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2017-05-26 | PHASE3 |
| NCT03801226 | COMPLETED | Potential Applications for Heart Failure; Volume Overload |
Yale University |
2018-12-01 | EARLY_PHASE1 |
| NCT02857283 | COMPLETED | Environmental Exposure; Nasal Inflammation |
University of North Carolina, Chapel Hill |
2017-04-22 | |
| NCT02632266 | COMPLETED | Complication of Prematurity |
University of Kansas Medical Center |
2015-07 | PHASE4 |
| NCT03914183 | COMPLETED | Injection Site Rotation; Diabete Mellitus |
Pink Pearls Inc |
2018-10-15 | |
| NCT02484092 | COMPLETED | Hemophilia B |
Pfizer |
2015-11-18 | PHASE2 |
| NCT03231033 | COMPLETED | Autoimmune Pulmonary Alveolar Proteinosis |
Children's Hospital Medical Center, Cincinnati |
2017-08-17 | PHASE1 |
| NCT03466073 | COMPLETED | Community-acquired Pneumonia |
BioAegis Therapeutics Inc. |
2018-08-28 | PHASE1; PHASE2 |
| NCT03709108 | COMPLETED | Type 1 Diabetes Mellitus |
University of Virginia |
2018-11-19 | |
| NCT03849612 | COMPLETED | Type 1 Diabetes Mellitus |
Eli Lilly and Company |
2019-02-21 | |
| NCT03723759 | COMPLETED | Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2018-10-26 | PHASE1 |
| NCT02192450 | COMPLETED | Type 1 Diabetes Mellitus; Nocturnal Hypoglycemia; Recurrent Severe Hypoglycaemia |
Nordsjaellands Hospital |
2015-01 | PHASE4 |
| NCT02251041 | COMPLETED | Reperfusion Injury |
Universitaire Ziekenhuizen KU Leuven |
2014-09 | PHASE2 |
| NCT03521258 | UNKNOWN | Wounds; Trauma; Injury; Limb Salvage; Soft Tissue Injuries |
Louisiana State University Health Sciences Center in New Orleans |
2016-02 | |
| NCT03138447 | COMPLETED | Diabetes Mellitus, Type 2 |
Amalgam Rx, Inc. |
2017-03-30 | |
| NCT00736632 | COMPLETED | Vitamin D Deficiency; Insulin Resistance; Type 2 Diabetes Mellitus; Cardiovascular Disease; Hypertension |
Washington University School of Medicine |
2006-05 | |
| NCT03063515 | COMPLETED | Diabetes Mellitus |
University of Miami |
2017-04-19 | PHASE1 |
| NCT03352674 | COMPLETED | Diabetes Mellitus |
Indonesia University |
2016-09 | PHASE2 |
| NCT03651024 | UNKNOWN | Erectile Dysfunction (ED) |
Sano V Pte Ltd |
2018-10 | |
| NCT02846233 | COMPLETED | Type 2 Diabetes Mellitus |
University of California, San Francisco |
2016-08 | |
| NCT02429037 | UNKNOWN | Advanced Head and Neck Cancer |
Shenzhen SiBiono GeneTech Co.,Ltd |
2015-05 | PHASE2 |
| NCT02355925 | COMPLETED | Infertility |
Royan Institute |
2014-10 | PHASE3 |
| NCT02561962 | COMPLETED | Multiple Myeloma |
Amgen |
2015-11-20 | PHASE1 |
| NCT03510091 | COMPLETED | Human Papillomavirus Infection |
Le Bonheur Children's Hospital |
2018-08-30 | |
| NCT04451655 | COMPLETED | Blood Glucose |
Audai A. Hayajneh |
2018-09-01 | |
| NCT03235349 | COMPLETED | Hepatitis C Virus (HCV) |
AbbVie |
2017-09-29 | PHASE3 |
| NCT03051243 | UNKNOWN | DM2 |
Rabin Medical Center |
2017-10-01 | PHASE3 |
| NCT02237846 | WITHDRAWN | Osteoarthritis of the Knee |
Translational Biosciences |
2014-09 | PHASE1; PHASE2 |
| NCT01578629 | COMPLETED | Ischemic Stroke; Transient Ischemic Attack (TIA) |
Andrew Slivka |
2012-03 | PHASE1; PHASE2 |
| NCT02378077 | COMPLETED | Obesity; Insulin Resistance |
Mayo Clinic |
2014-08 | |
| NCT03458715 | UNKNOWN | Type2 Diabetes |
Mackay Memorial Hospital |
2017-09-21 | PHASE4 |
| NCT01774565 | COMPLETED | Diabetes Mellitus |
University of Cambridge |
2016-08 | |
| NCT02694289 | WITHDRAWN | Type 2 Diabetes Mellitus |
Maya Guglin |
2016-11 | |
| NCT03214367 | COMPLETED | Type 1 Diabetes Mellitus |
Eli Lilly and Company |
2017-07-17 | PHASE3 |
| NCT03369327 | COMPLETED | Hepatitis C Virus Infection, Response to Therapy of; Human Immunodeficiency Virus |
Tehran University of Medical Sciences |
2017-01-01 | PHASE3 |
| NCT03214380 | COMPLETED | Type 2 Diabetes Mellitus |
Eli Lilly and Company |
2017-07-14 | PHASE3 |
| NCT03530436 | COMPLETED | Safety After Oral Intake; Pharmacokinetics After Oral Intake |
University of Hohenheim |
2018-06-07 | |
| NCT02267993 | COMPLETED | Thrombocytopenia |
Institute of Hematology & Blood Diseases Hospital, China |
2014-10 | PHASE4 |
| NCT03392441 | COMPLETED | Diabetes Mellitus, Type 1; Diabetes; Diabetes Complications |
Mayo Clinic |
2017-11-30 | |
| NCT03806829 | COMPLETED | Endothelial Dysfunction |
University of the Highlands and Islands |
2018-06-06 | |
| NCT03211858 | COMPLETED | Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus |
Sanofi |
2017-08-02 | PHASE3 |
| NCT01951716 | WITHDRAWN | Does the Vagus Nerve Mediate the Effects of Xenin-25 |
Washington University School of Medicine |
2013-01 | PHASE1 |
| NCT02490098 | WITHDRAWN | Type 1 Diabetes |
Institut de Recherches Cliniques de Montreal |
2018-01 | PHASE2 |
| NCT02624908 | UNKNOWN | Diabetes Mellitus, Type 2 |
Foundation for Atlanta Veterans Education and Research, Inc. |
2016-01 | PHASE4 |
| NCT02750410 | COMPLETED | Type 2 Diabetes |
Eli Lilly and Company |
2016-08 | PHASE4 |
| NCT02300909 | COMPLETED | Scarring; Spinal Stenosis; Herniated Disc |
MiMedx Group, Inc. |
2014-11 | |
| NCT02787551 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2016-07-06 | PHASE3 |
| NCT03032588 | COMPLETED | Healthy |
Janssen Vaccines & Prevention B.V. |
2017-10-09 | PHASE1 |
| NCT02749890 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2016-05-09 | PHASE3 |
| NCT03332849 | UNKNOWN | Type1 Diabetes Mellitus; Type2 Diabetes Mellitus |
Hanmi Pharmaceutical Company Limited |
2015-07-28 | PHASE1 |
| NCT02378779 | TERMINATED | Premature Ejaculation |
University Hospital, Brest |
2016-04-22 | |
| NCT03413267 | COMPLETED | Food Structure Impact on Micronutrient Bioavailability |
Françoise Nau |
2017-12-07 | |
| NCT03118349 | TERMINATED | Pancreatic Carcinoma; Tumors That Express CA 19-9 |
BioNTech Research & Development, Inc. |
2017-06-01 | PHASE1 |
| NCT03182569 | COMPLETED | Diabetic Ketoacidosis |
Hospital General de Niños Pedro de Elizalde |
2016-12-11 | |
| NCT02623478 | WITHDRAWN | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2018-01 | PHASE1 |
| NCT02449603 | COMPLETED | Type 2 Diabetes Mellitus |
Xijing Hospital |
2015-11 | PHASE4 |
| NCT02057900 | COMPLETED | Ischemic Heart Disease |
Assistance Publique - Hôpitaux de Paris |
2013-05-27 | PHASE1 |
| NCT03328117 | COMPLETED | Acute Lung Injury |
Exvastat Ltd. |
2017-11-13 | PHASE1 |
| NCT02451137 | COMPLETED | Diabetes Mellitus, Type 2 |
Sanofi |
2015-06-16 | PHASE4 |
| NCT02465359 | COMPLETED | Chronic Inflammatory Demyelinating Polyneuropathy |
University of South Florida |
2014-09 | |
| NCT03488992 | COMPLETED | Metabolic Syndrome |
USANA Health Sciences |
2017-01-10 | |
| NCT03428997 | COMPLETED | Comedogenicity |
Johnson & Johnson Consumer Inc. (J&JCI) |
2017-11-20 | |
| NCT02879877 | COMPLETED | Healthy Volunteers |
UCB Biopharma S.P.R.L. |
2016-07-11 | PHASE1 |
| NCT02940158 | COMPLETED | Healthy |
University of Guelph |
2016-10 | |
| NCT04501250 | COMPLETED | Pharmacokinetics; Bioequivalence |
Geropharm |
2017-10-23 | |
| NCT02877030 | COMPLETED | HTLV-1 |
Pedreira, Érika, M.D. |
2017-04-02 | |
| NCT02365363 | COMPLETED | Diabetes Prevention; Obesity Prevention |
University of Manitoba |
2016-10 | |
| NCT02964104 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2016-11-15 | PHASE1 |
| NCT03394508 | COMPLETED | Rhinitis; Asthma; Allergy |
Karolinska Institutet |
2013-01 | PHASE2; PHASE3 |
| NCT02606357 | COMPLETED | Diabetes Mellitus, Type 2 |
Sanofi |
2015-11-22 | PHASE4 |
| NCT03643380 | COMPLETED | Overactive Bladder |
Neuspera Medical, Inc. |
2017-08-17 | PHASE1 |
| NCT03091946 | COMPLETED | Blood Glucose; Subjective Hunger, Insulin |
PepsiCo Global R&D |
2017-08-01 | |
| NCT01755468 | COMPLETED | Type 2 Diabetes |
Mount Sinai Hospital, Canada |
2013-04 | PHASE3 |
| NCT03013764 | COMPLETED | Physical Inactivity; Dietary Protein |
University of Missouri-Columbia |
2015-10 | |
| NCT02460978 | COMPLETED | Type 1 Diabetes Mellitus |
AstraZeneca |
2015-07-08 | PHASE3 |
| NCT01941745 | COMPLETED | Respiratory Distress Syndrome in Premature Infant; Bronchopulmonary Dysplasia |
Tufts Medical Center |
2013-10 | PHASE2 |
| NCT01619020 | COMPLETED | Healthy |
Fred Hutchinson Cancer Center |
2012-10 | |
| NCT03177096 | COMPLETED | Type1diabetes |
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace |
2016-09-20 | |
| NCT01814436 | UNKNOWN | Dental Pulp Necrosis; Permanent Incisor Avulsed by Trauma |
Air Force Military Medical University, China |
2013-02 | |
| NCT03056456 | COMPLETED | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2017-02-23 | PHASE1 |
| NCT02582814 | COMPLETED | Type 1 Diabetes Mellitus |
AstraZeneca |
2015-10-26 | PHASE3 |
| NCT03198676 | COMPLETED | Upper Respiratory Tract Infections |
Prep Biopharm Limited |
2017-05-08 | PHASE1 |
| NCT03155867 | COMPLETED | Diabetes |
Société des Produits Nestlé (SPN) |
2017-04-05 | |
| NCT03121339 | COMPLETED | Seasonal Influenza Preventative Vaccine Pharmacodynamics |
Vaxart |
2017-03-31 | PHASE1 |
| NCT02877667 | COMPLETED | Tattoo |
Soliton |
2016-07 | |
| NCT03294161 | COMPLETED | Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis; American |
Hospital Universitário Professor Edgard Santos |
2014-12 | PHASE2 |
| NCT02789527 | COMPLETED | Healthy |
Estella S. Poloni |
2015-11 | |
| NCT02390466 | UNKNOWN | HIV |
InnaVirVax |
2015-04 | PHASE1; PHASE2 |
| NCT02069379 | COMPLETED | Depression; Insulin Resistance; Metabolic Syndrome |
University of Michigan |
2014-07 | PHASE4 |
| NCT03387293 | COMPLETED | Pediatric Obesity |
TC Erciyes University |
2016-11-01 | |
| NCT01785108 | COMPLETED | Diabetes Mellitus, Type 1 |
Johnny Ludvigsson |
2013-02 | PHASE2 |
| NCT02527096 | COMPLETED | HIV-1 Infection |
ANRS, Emerging Infectious Diseases |
2015-09-17 | PHASE2 |
| NCT02897557 | COMPLETED | Type 1 Diabetes |
Insulet Corporation |
2016-09 | |
| NCT02634528 | COMPLETED | Diabetes Mellitus |
Julphar Gulf Pharmaceutical Industries |
2016-11-16 | PHASE1 |
| NCT02244073 | TERMINATED | Critical Illness |
Hospices Civils de Lyon |
2015-05 | |
| NCT03065595 | COMPLETED | Malnutrition |
Indonesia University |
2016-10-05 | PHASE4 |
| NCT00506272 | UNKNOWN | Diabetes Mellitus; Hyperglycemia; Hypoglycemia |
Atlanta VA Medical Center |
2007-12 | |
| NCT03510221 | COMPLETED | Hypertension; Oxidative Stress; Autonomic Imbalance; Insulin Resistance |
University of Sao Paulo General Hospital |
2016-01 | |
| NCT01754454 | UNKNOWN | Acute GVH Disease |
Affiliated Hospital to Academy of Military Medical Sciences |
2012-12 | PHASE1; PHASE2 |
| NCT00419562 | COMPLETED | Diabetes Mellitus, Type 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2007-02 | PHASE3 |
| NCT03106870 | COMPLETED | Gestational Diabetes Mellitus in Pregnancy |
Ain Shams University |
2016-06 | |
| NCT02532101 | TERMINATED | Uncontrolled Insulin-treated Type 2 Diabetes Mellitus |
Universiti Sains Malaysia |
2014-12 | |
| NCT02922673 | COMPLETED | Endotoxemia |
Radboud University Medical Center |
2016-09 | |
| NCT02933645 | COMPLETED | Insulin Resistance |
Turku University Hospital |
2016-04 | |
| NCT02635243 | WITHDRAWN | Type 1 Diabetes Mellitus |
Sanofi |
2016-04 | PHASE1 |
| NCT02420262 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2015-07-26 | PHASE3 |
| NCT03272074 | COMPLETED | Diabetes Mellitus, Type 2; Obesity; Pre Diabetes |
Florida State University |
2015-09-11 | |
| NCT01684943 | COMPLETED | Type 1 Diabetes |
Massachusetts General Hospital |
2010-07 | |
| NCT01751386 | COMPLETED | Alcoholism; Alcohol Dependence; Alcohol Drinking Related Problems; Alcohol Drinking; Anxiety Disorder |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2012-12-03 | PHASE2 |
| NCT03558321 | COMPLETED | Postmenopausal Bleeding |
Cairo University |
2014-06 | |
| NCT02124681 | COMPLETED | Insulin Resistance |
University of Pittsburgh |
2014-04 | PHASE1 |
| NCT01879891 | COMPLETED | Healthy Women |
University of Alabama at Birmingham |
1995-05 | |
| NCT02078193 | COMPLETED | Kidney Transplantation |
East Carolina University |
2013-11 | PHASE4 |
| NCT02036515 | COMPLETED | Type 2 Diabetes Mellitus |
Merck Sharp & Dohme LLC |
2014-03-12 | PHASE3 |
| NCT02312492 | COMPLETED | Dyslipidemia |
Tufts University |
2013-01 | |
| NCT02660502 | COMPLETED | Healthy |
Adocia |
2016-01 | PHASE1 |
| NCT01781234 | COMPLETED | Tobacco Abstinence Syndrome |
Ajna Hamidovic |
2013-08 | PHASE2 |
| NCT02040558 | TERMINATED | Advanced Solid Tumors |
Mallinckrodt |
2013-07 | PHASE1 |
| NCT02061722 | COMPLETED | Huntington's Disease |
CHDI Foundation, Inc. |
2013-01 | EARLY_PHASE1 |
| NCT02568280 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2015-10-06 | PHASE1 |
| NCT01783847 | COMPLETED | Traumatic Optic Neuropathy |
Tehran University of Medical Sciences |
2015-02 | PHASE1; PHASE2 |
| NCT02079805 | COMPLETED | Essential Hypertension Complicated by Type 2 Diabetes Mellitus |
Takeda |
2014-06 | PHASE4 |
| NCT02321410 | COMPLETED | Carotid Artery Disease; Plaque Neovascularization |
Ospedale San Giovanni Bellinzona |
2014-02 | |
| NCT02790645 | COMPLETED | Diabetes Mellitus, Type 1 |
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
2012-09 | |
| NCT02714166 | COMPLETED | Sunscreening Agents |
Bayer |
2016-02-26 | |
| NCT02401243 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2015-03 | PHASE3 |
| NCT01375556 | TERMINATED | Alcoholism; Genetics |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
2011-05-26 | PHASE1 |
| NCT02201004 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2014-06 | PHASE4 |
| NCT02041975 | COMPLETED | Obesity |
University of Reading |
2013-10 | |
| NCT02328040 | COMPLETED | Diabetes Mellitus, Type 1 |
Albert Einstein College of Medicine |
2014-09 | PHASE1 |
| NCT02034331 | COMPLETED | Spinal Cord Injury; Insulin Resistance |
James J. Peters Veterans Affairs Medical Center |
2012-12 | |
| NCT02155374 | COMPLETED | Hyperglycemia Steroid-induced |
Slotervaart Hospital |
2014-05 | PHASE4 |
| NCT01291030 | COMPLETED | Glucose Metabolism; Renal Transplantation |
University Hospital, Ghent |
2011-01 | |
| NCT02026310 | COMPLETED | Diabetes Mellitus, Type 2 |
Qifu Li |
2014-01 | |
| NCT03330678 | COMPLETED | Probiotics |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2013-12 | |
| NCT02439047 | TERMINATED | Cancer |
Centre Oscar Lambret |
2015-06 | |
| NCT01665573 | COMPLETED | Fear Conditioning |
Yale University |
2012-07-17 | EARLY_PHASE1 |
| NCT00957671 | COMPLETED | Growth Hormone Deficiency; Traumatic Brain Injury |
The University of Texas Medical Branch, Galveston |
2003-11 | PHASE4 |
| NCT02077348 | COMPLETED | Diabetes Mellitus Type I; Ketoacidosis |
University of Aarhus |
2014-05 | |
| NCT02740790 | COMPLETED | Human Papillomavirus |
Shanghai Zerun Biotechnology Co.,Ltd |
2013-09 | PHASE2 |
| NCT02438670 | COMPLETED | Type 1 Diabetes Mellitus |
Sansum Diabetes Research Institute |
2015-05 | |
| NCT02443714 | COMPLETED | Healthy |
Chongqing Medical University |
2015-04 | PHASE4 |
| NCT01950325 | COMPLETED | HIV-1 Infection; Neutralizing Antibody; Monoclonal Antibody; Viral Load; HIV Antibodies |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-08-22 | PHASE1 |
| NCT02216799 | COMPLETED | Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition |
King Faisal Specialist Hospital & Research Center |
2013-03 | PHASE4 |
| NCT02023918 | COMPLETED | Diabetes; Metabolic Syndrome; Insulin Resistance |
University of California, San Francisco |
2014-01 | PHASE2 |
| NCT01589653 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2012-05-26 | PHASE4 |
| NCT03956433 | COMPLETED | Metabolic Syndrome |
University of Leeds |
2014-09-01 | |
| NCT02080026 | COMPLETED | Malaria |
Radboud University Medical Center |
2014-06 | |
| NCT02261168 | COMPLETED | Diabetes Mellitus, Type 2; Insulin Resistance |
Maastricht University Medical Center |
2014-11 | |
| NCT02059694 | WITHDRAWN | Upper Eyelid Surgery |
Duke University |
||
| NCT02148861 | COMPLETED | Diabetes; Type 2 Diabetes Mellitus |
Novo Nordisk A/S |
2014-05-26 | PHASE1 |
| NCT02338089 | COMPLETED | Postpartum Hemorrhage |
Samuel Lunenfeld Research Institute, Mount Sinai Hospital |
2015-01 | |
| NCT01149005 | UNKNOWN | Cystic Fibrosis; Impaired Glucose Tolerance; Pulmonary Exacerbation |
Hadassah Medical Organization |
2010-06 | |
| NCT01984801 | COMPLETED | Acne Vulgaris |
GlaxoSmithKline |
2013-10-14 | PHASE1 |
| NCT01988792 | COMPLETED | Premature; Infant; Enteral Nutrition; Human Milk; Fortification |
University of Tennessee |
2013-11 | |
| NCT01127659 | COMPLETED | Hypogonadism |
University at Buffalo |
2010-05 | PHASE4 |
| NCT01472328 | COMPLETED | Obesity; Non-insulin-dependent Diabetes Mellitus |
German Diabetes Center |
2012-03 | |
| NCT02199028 | COMPLETED | Type 1 Diabetes Mellitus |
Stanford University |
2014-07 | PHASE1 |
| NCT01941277 | TERMINATED | Prediabetic State |
Alere San Diego |
2014-08 | |
| NCT01858597 | COMPLETED | Gestational Diabetes Mellitus |
First Affiliated Hospital, Sun Yat-Sen University |
2013-03 | |
| NCT02002221 | COMPLETED | Type 2 Diabetes Mellitus (T2DM) |
Novartis Pharmaceuticals |
2013-12 | PHASE4 |
| NCT03699189 | COMPLETED | Diabetes Mellitus, Type 1 |
Rosa María Sánchez Hernández |
2011-11 | |
| NCT02401113 | COMPLETED | Sarcopenia |
Pusan National University Hospital |
2014-11 | PHASE2; PHASE3 |
| NCT02157298 | COMPLETED | Type 2 Diabetes Mellitus |
AstraZeneca |
2014-06 | PHASE4 |
| NCT02549053 | COMPLETED | Barrett Esophagus |
University Hospital, Angers |
2012-02 | |
| NCT01443741 | UNKNOWN | Diabetes Insulin Dependent |
University Hospital, Angers |
2012-01 | PHASE2 |
| NCT02320838 | COMPLETED | Pain |
University of Castilla-La Mancha |
2014-11 | |
| NCT01994746 | COMPLETED | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2013-11 | PHASE3 |
| NCT02370121 | COMPLETED | Metabolic Syndrome |
University of Guadalajara |
2013-02 | PHASE2 |
| NCT01951508 | COMPLETED | Healthy; Substance-related Disorder; Mood Disorder |
University Hospital, Basel, Switzerland |
2013-10 | EARLY_PHASE1 |
| NCT01886989 | COMPLETED | Type 2 Diabetes |
Arpita Basu |
2012-01 | |
| NCT01124981 | COMPLETED | Fibrinogen Deficiency in Complex Cardiac Surgery |
Isala |
2011-02 | PHASE2; PHASE3 |
| NCT01952145 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2013-09-20 | PHASE3 |
| NCT01991548 | COMPLETED | Type 1 Diabetes; Type 2 Diabetes |
Medtronic MiniMed, Inc. |
2013-11 | |
| NCT00734448 | UNKNOWN | Gestational Diabetes Mellitus |
University of Messina |
2013-11 | |
| NCT02221323 | COMPLETED | Diabetes Mellitus |
Profil Institut für Stoffwechselforschung GmbH |
2014-09 | PHASE2 |
| NCT02073656 | COMPLETED | Hepatitis C Virus; HIV |
Gilead Sciences |
2014-02 | PHASE3 |
| NCT01561378 | COMPLETED | Post-operative Cognitive Decline; Post-operative Delirium |
Albert Einstein College of Medicine |
2012-08 | PHASE2 |
| NCT02194517 | COMPLETED | Type 1 Diabetes Mellitus |
Medical University of Warsaw |
2013-04 | |
| NCT02205554 | COMPLETED | Pain |
Syntrix Biosystems, Inc. |
2014-08 | PHASE1 |
| NCT01245322 | COMPLETED | Bacterial Vaginosis |
Skaraborg Hospital |
2007-01 | PHASE4 |
| NCT02328404 | COMPLETED | Polycystic Ovary Syndrome; Hypovitaminosis D |
Hayat Pharmaceutical Co. PLC |
2014-02 | PHASE3 |
| NCT02099409 | COMPLETED | Type 1 Diabetes Mellitus |
Centre Hospitalier du Luxembourg |
2014-01 | |
| NCT01386294 | COMPLETED | HIV Prevention |
CONRAD |
2011-10 | PHASE3 |
| NCT03392961 | COMPLETED | Type 2 Diabetes Mellitus |
Biocon Limited |
2014-03-27 | PHASE1 |
| NCT02131246 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2014-05 | PHASE1 |
| NCT01282164 | COMPLETED | Adult Growth Hormone Deficiency; Hypothalamic-pituitary Disorders |
The Cleveland Clinic |
2011-01 | |
| NCT02018263 | COMPLETED | Cocaine Dependence |
Yale University |
2013-10 | PHASE1 |
| NCT01753674 | TERMINATED | Metabolic Syndrome; Insulin Resistance |
University of Connecticut |
2013-01 | PHASE1 |
| NCT01392898 | UNKNOWN | Type 2 Diabetes Mellitus |
Radboud University Medical Center |
2012-02 | |
| NCT01880736 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2013-06 | PHASE3 |
| NCT00862875 | COMPLETED | Type 2 Diabetes |
Institut de Recherches Cliniques de Montreal |
2009-03 | PHASE4 |
| NCT01969747 | COMPLETED | Diabetes Mellitus, Type 1 |
Boehringer Ingelheim |
2013-11 | PHASE2 |
| NCT02165566 | COMPLETED | Hyperglycemia |
University of Roma La Sapienza |
2013-03 | PHASE4 |
| NCT02333851 | TERMINATED | Type 2 Diabetes Mellitus |
Hospital Universitario Central de Asturias |
2013-06 | PHASE4 |
| NCT01541592 | COMPLETED | Insulin Resistance |
Mayo Clinic |
2012-03 | |
| NCT01722526 | COMPLETED | Human Acid Sphingomyelinase Deficiency |
Genzyme, a Sanofi Company |
2013-03 | PHASE1 |
| NCT01497197 | TERMINATED | Infertility; Fertility; Follicle Stimulating Hormone Deficiency |
Merck KGaA, Darmstadt, Germany |
2012-05 | PHASE3 |
| NCT01747980 | COMPLETED | Gaucher Disease |
Protalix |
2013-03 | PHASE1 |
| NCT01435616 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2011-11 | PHASE3 |
| NCT02017132 | UNKNOWN | Obesity; Diabetes; Cardiovascular Disease |
Queen Margaret University |
2013-04 | |
| NCT01218594 | UNKNOWN | Non-small Cell Lung Cancer |
Sun Yat-sen University |
2009-05 | PHASE2 |
| NCT01557634 | UNKNOWN | Type 1 Diabetes |
Daniela Elleri |
2012-12 | PHASE2 |
| NCT01840358 | UNKNOWN | Type 1 Diabetes |
St. Justine's Hospital |
2013-04 | |
| NCT03034291 | COMPLETED | Insulin Resistance |
Universidad de Antioquia |
2012-05 | |
| NCT00877513 | TERMINATED | Cardiovascular Disease; Insulin Resistance |
Charles Drew University of Medicine and Science |
2009-02 | |
| NCT01244178 | UNKNOWN | Sepsis |
peter metrakos |
2010-11 | |
| NCT03771326 | COMPLETED | Kisspeptin Action on Insulin in Healthy Normal Men; Kisspeptin Action on Insulin in Obese Diabetic Men |
Quaid-e-Azam University |
2013-10-29 | PHASE3 |
| NCT01689142 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2012-09 | PHASE3 |
| NCT01666028 | COMPLETED | Type 1 Diabetes |
University of Cambridge |
2012-11 | PHASE2 |
| NCT01685333 | COMPLETED | Healthy |
Azidus Brasil |
2013-02-28 | PHASE1 |
| NCT01617434 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2012-09 | PHASE3 |
| NCT01483248 | UNKNOWN | Liver Cirrhosis; Fibrosis; Liver Disease; Digestive System Disease |
S-Evans Biosciences Co., Ltd. |
2010-10 | PHASE1; PHASE2 |
| NCT01919385 | COMPLETED | Type 1 Diabetes |
Animas Corporation |
2013-07 | PHASE1 |
| NCT01552603 | COMPLETED | Type I Diabetes Mellitus |
Legacy Health System |
2012-03 | PHASE2 |
| NCT01437163 | COMPLETED | Androgenetic Alopecia |
Apira Science, Inc. |
2011-09 | |
| NCT01676233 | COMPLETED | Type 1 Diabetes Mellitus |
Sanofi |
2012-09 | PHASE1 |
| NCT01513473 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2012-01-16 | PHASE3 |
| NCT01734057 | WITHDRAWN | Purpura; Idiopathic Thrombocytopenic Purpura |
Shandong University |
2012-07 | PHASE3 |
| NCT01879813 | COMPLETED | Cognitive Performance (Focus) |
University of Leeds |
2012-10 | |
| NCT00829699 | COMPLETED | Type 2 Diabetes |
University of Maryland, Baltimore |
2009-07 | EARLY_PHASE1 |
| NCT01009567 | COMPLETED | Ovarian Hyperstimulation Syndrome |
Royan Institute |
2009-06 | PHASE1; PHASE2 |
| NCT00719212 | COMPLETED | Ovarian Neoplasms |
Translational Research in Oncology |
2009-01 | PHASE2 |
| NCT01305356 | COMPLETED | Degenerative Joint Disease; Congenital Deformity; Arthritis; Osteoarthritis; Rheumatoid Arthritis |
BioMimetic Therapeutics |
2011-03 | |
| NCT01483352 | COMPLETED | Diabetes Mellitus, Type 1 |
Hoffmann-La Roche |
2011-11 | |
| NCT01541735 | COMPLETED | Type 2 Diabetes |
Coordinación de Investigación en Salud, Mexico |
2012-01 | PHASE2; PHASE3 |
| NCT01555788 | COMPLETED | Type 1 Diabetes Mellitus |
University Hospital, Montpellier |
2012-02 | |
| NCT00313716 | COMPLETED | Anemia; Traumatic Brain Injury |
Claudia Sue Robertson |
2006-04 | PHASE2; PHASE3 |
| NCT02974894 | COMPLETED | Stress Reaction |
Lund University |
2013-02 | |
| NCT01774084 | COMPLETED | Insulin Sensitivity |
Karolinska Institutet |
2012-01 | PHASE4 |
| NCT02133495 | COMPLETED | Lower Eyelid Retraction |
SGM Physician Research Consortium |
2011-01 | |
| NCT01719640 | COMPLETED | Diabetes Mellitus, Type 2 |
Fuzhou General Hospital |
2011-01 | PHASE1; PHASE2 |
| NCT01007071 | COMPLETED | Hypopituitarism |
Stanford University |
2009-11-01 | PHASE3 |
| NCT00965549 | COMPLETED | Diabetes Mellitus, Type 2 |
Sanofi |
2009-07 | PHASE4 |
| NCT00766857 | COMPLETED | Type 2 Diabetes Mellitus; Congestive Heart Failure |
Amsterdam UMC, location VUmc |
2009-05 | PHASE4 |
| NCT01766557 | COMPLETED | Insulin Sensitivity; Polycystic Ovarian Syndrome |
Laval University |
2010-08 | |
| NCT01624038 | UNKNOWN | Thalassemia Intermedia |
Ain Shams University |
2012-06 | PHASE2; PHASE3 |
| NCT00657943 | COMPLETED | Type 2 Diabetes; Atherosclerosis; Arteriosclerosis |
Steno Diabetes Center Copenhagen |
2008-04 | PHASE4 |
| NCT01312246 | WITHDRAWN | Colon and Rectal Diseases |
University of Illinois at Chicago |
2011-04 | |
| NCT01117350 | COMPLETED | Diabetes Mellitus, Type 2 |
Sanofi |
2010-07 | PHASE4 |
| NCT01202474 | COMPLETED | Diabetes Mellitus, Type 1 |
Sanofi |
2011-05 | PHASE4 |
| NCT01440842 | COMPLETED | Stress Hyperglycaemia |
University of Cambridge |
2012-05 | PHASE2 |
| NCT01271829 | COMPLETED | Satiety; Glycemic Index; Insulin; Gastrointestinal Peptides and Hormones |
Loma Linda University |
2011-01 | |
| NCT00960661 | COMPLETED | Type 2 Diabetes Mellitus |
AstraZeneca |
2009-09 | PHASE3 |
| NCT01341912 | COMPLETED | Severe Hemophilia A |
Octapharma |
2011-06 | PHASE3 |
| NCT02025686 | COMPLETED | Pain; Inflammation; Hyperalgesia |
Per Rotbøll Nielsen |
2012-03 | |
| NCT00690534 | COMPLETED | Sarcopenia |
The University of Texas Medical Branch, Galveston |
2005-09 | PHASE1 |
| NCT01158417 | TERMINATED | Type 2 Diabetes; Obesity; Insulin Resistance |
University at Buffalo |
2008-12 | |
| NCT01735370 | COMPLETED | Fasting |
IPCA Laboratories Ltd. |
2012-05 | PHASE1 |
| NCT01649024 | UNKNOWN | Malignant Mesothelioma |
Azienda Ospedaliera Universitaria Senese |
2009-05 | PHASE2 |
| NCT01572402 | COMPLETED | Type 2 Diabetes; Postprandial Oxidative Stress |
Institute for Clinical and Experimental Medicine |
2012-01 | |
| NCT01629277 | COMPLETED | Type 1 Diabetes |
University of Cambridge |
2011-07 | PHASE2 |
| NCT01503216 | COMPLETED | Vitamin D Deficiency |
Ulrike Lehmann |
2012-01 | |
| NCT01490762 | COMPLETED | Healthy |
Mannkind Corporation |
2011-12 | PHASE1 |
| NCT01438749 | COMPLETED | Healthy Volunteer |
Hoffmann-La Roche |
2011-10 | PHASE1 |
| NCT01011868 | COMPLETED | Diabetes Mellitus, Type 2 |
Boehringer Ingelheim |
2009-11 | PHASE2 |
| NCT01182883 | WITHDRAWN | Brain Stem Neoplasms; Glioma; Pinealoma |
National Cancer Institute (NCI) |
2010-07-28 | PHASE1 |
| NCT01432275 | COMPLETED | Diabetes Mellitus |
Abbott Diabetes Care |
2011-09 | |
| NCT00722839 | COMPLETED | Nonneoplastic Condition |
City of Hope Medical Center |
2006-12 | PHASE1 |
| NCT01435330 | COMPLETED | Insulin Resistance |
Novartis Pharmaceuticals |
2011-03 | PHASE1 |
| NCT01268150 | COMPLETED | Locally Recurrent; Metastatic Breast Cancer ( HER2 Negative) |
Eisai Inc. |
2011-02 | PHASE2 |
| NCT02185729 | COMPLETED | Diseases, Metabolic; Insulin Sensitivity |
Emory University |
2008-06 | PHASE2; PHASE3 |
| NCT01191268 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2010-11 | PHASE3 |
| NCT00604175 | COMPLETED | HIV Infections; Sexually Transmitted Diseases |
National Institute of Allergy and Infectious Diseases (NIAID) |
2008-02 | PHASE2 |
| NCT00967837 | TERMINATED | Wound Healing; Diabetes |
Florida Atlantic University |
2006-01 | PHASE2; PHASE3 |
| NCT00913497 | COMPLETED | Type 1 Diabetes Mellitus |
Corewell Health West |
2009-06 | PHASE4 |
| NCT01265875 | COMPLETED | Chronic Pancreatitis |
ChiRhoClin, Inc. |
2010-12 | PHASE1; PHASE2 |
| NCT00673894 | COMPLETED | Type 2 Diabetes |
Garvan Institute of Medical Research |
2008-04 | |
| NCT01420302 | COMPLETED | Critical Illness |
Greet Van den Berghe |
2011-08 | |
| NCT01356823 | COMPLETED | Cervical Intraepithelial Neoplasia; Cervical Cancer |
Xiamen University |
2011-03 | PHASE2 |
| NCT02305069 | COMPLETED | Obesity; Sarcopenia |
University of Nottingham |
2009-10 | |
| NCT00989196 | COMPLETED | Hemophilia A |
Octapharma |
2010-05 | PHASE2 |
| NCT01416324 | COMPLETED | Diabetes Mellitus, Type 2 |
GlaxoSmithKline |
2011-06-15 | PHASE1 |
| NCT01367886 | COMPLETED | Overactive Bladder |
Washington University School of Medicine |
2010-08 | |
| NCT01056549 | COMPLETED | Hyperlipidemia |
University Health Network, Toronto |
2010-01 | |
| NCT01106729 | COMPLETED | Metabolism and Clearance of Cyanidin 3 Glucoside |
University of East Anglia |
2011-07 | |
| NCT01109316 | COMPLETED | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2010-04 | PHASE3 |
| NCT01334151 | COMPLETED | Diabetes Mellitus Type 1 |
Biodel |
2011-03 | PHASE1 |
| NCT01063361 | COMPLETED | Type 2 Diabetes |
University of Toronto |
2010-02 | PHASE2 |
| NCT01209403 | COMPLETED | Kidney Failure, Chronic |
University of Aarhus |
2010-09 | PHASE4 |
| NCT01342250 | COMPLETED | Liver Cirrhosis |
Shenzhen Beike Bio-Technology Co., Ltd. |
2010-10 | PHASE1; PHASE2 |
| NCT03209895 | COMPLETED | Joint Pain |
U.S. Nutraceuticals, LLC |
2010-10-08 | |
| NCT01399346 | COMPLETED | Type 1 Diabetes |
Medical University of Graz |
2011-04 | PHASE1 |
| NCT04874324 | COMPLETED | Pharmacokinetics |
Wockhardt |
2011-03-17 | PHASE1 |
| NCT01310478 | UNKNOWN | Colorectal Neoplasm |
Fudan University |
2010-08 | PHASE1 |
| NCT01349855 | COMPLETED | Type 1 Diabetes Mellitus |
Sanofi |
2011-03 | PHASE1 |
| NCT00228904 | WITHDRAWN | Diabetic Neuropathy |
Florida Atlantic University |
2005-02 | PHASE2; PHASE3 |
| NCT00528918 | COMPLETED | Diabetes Mellitus, Type II |
Carl T. Hayden VA Medical Center |
2007-06 | |
| NCT01076842 | COMPLETED | Diabetes Type 2 |
Novo Nordisk A/S |
2008-04 | PHASE4 |
| NCT00994266 | COMPLETED | Type 2 Diabetes |
Catalysis SL |
2009-10 | PHASE3 |
| NCT00971997 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2009-09 | PHASE4 |
| NCT00953472 | TERMINATED | Hypertension Stage 1 |
Mayo Clinic |
2009-02 | PHASE1 |
| NCT01271517 | UNKNOWN | Diabetes Mellitus Type 1 |
Karolinska Institutet |
2005-09 | PHASE4 |
| NCT00250211 | COMPLETED | Glioblastoma; Glioma |
AHS Cancer Control Alberta |
2005-03 | PHASE1; PHASE2 |
| NCT01025492 | TERMINATED | Dyslipidemia |
University of Utah |
2009-11 | PHASE4 |
| NCT01380366 | COMPLETED | Short Bowel Syndrome |
Northwestern University |
2006-10 | PHASE4 |
| NCT01365117 | COMPLETED | Healthy Volunteers |
Mannkind Corporation |
2011-01 | PHASE1 |
| NCT03409510 | COMPLETED | Healthy Volunteers |
Bispebjerg Hospital |
2010-11-01 | |
| NCT00283400 | TERMINATED | Subarachnoid Hemorrhage |
Baylor College of Medicine |
2006-01 | |
| NCT01067118 | WITHDRAWN | Diabetes Mellitus |
Stanford University |
2010-04 | PHASE2 |
| NCT00785538 | COMPLETED | Advanced Solid Tumors |
Eli Lilly and Company |
2005-10 | PHASE1 |
| NCT01691469 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2011-01 | PHASE1 |
| NCT01059812 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2010-02-01 | PHASE3 |
| NCT00775164 | WITHDRAWN | Obesity; Insulin Resistance |
University of Minnesota |
2009-01 | PHASE4 |
| NCT01074268 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2010-02 | PHASE3 |
| NCT00659165 | COMPLETED | Diabetes Mellitus |
University of New Mexico |
2008-04 | |
| NCT00906529 | WITHDRAWN | Type 2 Diabetes |
University of Texas Southwestern Medical Center |
2009-05 | PHASE4 |
| NCT00982228 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2009-09-01 | PHASE3 |
| NCT01163721 | COMPLETED | Diabetes Mellitus, Type 2 |
Gilead Sciences |
2010-06 | PHASE2 |
| NCT00664534 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2008-04 | PHASE4 |
| NCT00774878 | TERMINATED | Breast Neoplasms |
Sanofi |
2008-10 | PHASE2 |
| NCT00748137 | UNKNOWN | Type 1 Diabetes |
John Hunter Children's Hospital |
2008-03 | |
| NCT01045707 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2010-01 | PHASE3 |
| NCT00181610 | COMPLETED | Lactation |
Massachusetts General Hospital |
2004-09 | PHASE2 |
| NCT00795600 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2009-04 | PHASE4 |
| NCT01075022 | UNKNOWN | Insulin Resistance; Glucose Intolerance |
Hospital de Clinicas de Porto Alegre |
2009-05 | |
| NCT01201590 | COMPLETED | Insulin Resistance |
University of Nottingham |
2009-03 | |
| NCT00829062 | WITHDRAWN | Type 1 Diabetes |
Children's Mercy Hospital Kansas City |
2009-01 | |
| NCT00888732 | COMPLETED | Diabetes Mellitus, Type 1 |
University of Aarhus |
2009-06 | PHASE3 |
| NCT00791076 | TERMINATED | Diabetes Mellitus, Type 1 |
Johns Hopkins University |
2007-10 | PHASE2 |
| NCT01223560 | COMPLETED | Type 1 Diabetes |
Hvidovre University Hospital |
2009-10 | |
| NCT00978627 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2009-08 | PHASE3 |
| NCT01011296 | COMPLETED | Healthy Volunteers |
Pfizer |
2009-12 | PHASE1 |
| NCT00513526 | COMPLETED | Infection; Precancerous Condition |
AIDS Malignancy Consortium |
2007-11 | PHASE2 |
| NCT00570960 | TERMINATED | Spontaneous Bacterial Peritonitis |
University of Virginia |
2007-06 | PHASE4 |
| NCT00943709 | WITHDRAWN | Hyperglycemia; Leukemia |
University of Medicine and Dentistry of New Jersey |
2009-05 | PHASE3 |
| NCT00916448 | COMPLETED | Endotoxemia; Inflammation; Multi Organ Dysfunction Syndrome; Sepsis |
Radboud University Medical Center |
2009-05 | |
| NCT00699686 | COMPLETED | Type 2 Diabetes; Endothelial Dysfunction; Cardiovascular Disease |
University of Padova |
2008-05 | PHASE4 |
| NCT00600054 | COMPLETED | Recurrent Diffuse Pontine Gliomas |
YM BioSciences |
2007-10 | PHASE2 |
| NCT01411930 | COMPLETED | Diabetes |
Veterans Medical Research Foundation |
2009-03 | PHASE4 |
| NCT00593489 | COMPLETED | Diabetes Mellitus |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2006-07 | |
| NCT00438321 | TERMINATED | Metabolic Syndrome |
Massachusetts General Hospital |
2006-09 | PHASE1 |
| NCT00972582 | COMPLETED | Healthy |
The Hospital for Sick Children |
2009-05 | PHASE1 |
| NCT00292981 | COMPLETED | Hereditary Angioedema |
CSL Behring |
2005-08 | PHASE3 |
| NCT00548444 | COMPLETED | Tuberculosis |
University of Oxford |
2007-10 | PHASE1 |
| NCT01484457 | COMPLETED | Diabetes Mellitus, Type 1 |
Sansum Diabetes Research Institute |
2008-07 | EARLY_PHASE1 |
| NCT00207402 | COMPLETED | Hepatitis C |
Brooke Army Medical Center |
2005-10 | PHASE4 |
| NCT01060722 | COMPLETED | Healthy |
OPKO Health, Inc. |
2009-10 | PHASE1 |
| NCT00646568 | COMPLETED | Infertility |
Hadassah Medical Organization |
2008-06 | |
| NCT00832663 | COMPLETED | Muscle Damage |
Bispebjerg Hospital |
2009-04 | |
| NCT01006889 | COMPLETED | Nonalcoholic Fatty Liver Disease; Type 2 Diabetes Mellitus |
University of Florida |
2008-01 | PHASE4 |
| NCT00773175 | COMPLETED | Dehydration |
Halozyme Therapeutics |
2008-10 | PHASE4 |
| NCT00320112 | COMPLETED | Diabetes |
US Department of Veterans Affairs |
2007-02 | PHASE3 |
| NCT00667732 | COMPLETED | Type 2 Diabetes |
Oregon Health and Science University |
2007-03 | PHASE4 |
| NCT00910390 | COMPLETED | Human Embryo Cryopreservation |
Erasme University Hospital |
2009-04 | |
| NCT00613288 | COMPLETED | Hypogonadism |
University of Aarhus |
2007-09 | |
| NCT00780026 | COMPLETED | Liver Transplant |
University of Michigan |
2008-07 | PHASE4 |
| NCT01014832 | COMPLETED | Diabetes |
Hygieia, Inc |
2008-12 | |
| NCT00788840 | COMPLETED | Type 2 Diabetes Mellitus; Obesity |
University of Surrey |
2008-01 | PHASE4 |
| NCT00228891 | TERMINATED | Diabetes Mellitus, With Complications |
Florida Atlantic University |
2004-02 | PHASE2; PHASE3 |
| NCT00910767 | COMPLETED | Type 1 Diabetes |
University of Cambridge |
2009-02 | |
| NCT00776165 | COMPLETED | Chemotherapy-Induced Neutropenia |
Shantha Biotechnics Limited |
2007-10 | PHASE3 |
| NCT00858923 | UNKNOWN | HIV; HIV Infections |
Energex Systems, Inc. |
2008-07 | PHASE1 |
| NCT00699426 | COMPLETED | Type 2 Diabetes |
Lise Tarnow |
2008-06 | PHASE3 |
| NCT00820807 | TERMINATED | Insulin Resistance |
Cargill |
2009-01 | |
| NCT00160485 | WITHDRAWN | Gestational Diabetes |
Tripler Army Medical Center |
2004-06 | PHASE4 |
| NCT00673231 | COMPLETED | Type 2 Diabetes |
AstraZeneca |
2008-04 | PHASE3 |
| NCT00473876 | COMPLETED | Congestive Heart Failure; Insulin Resistance |
University of Dundee |
2007-08 | PHASE4 |
| NCT01823822 | COMPLETED | Anorexia Nervosa |
University Hospital, Geneva |
2008-06 | PHASE2; PHASE3 |
| NCT00627471 | TERMINATED | Type 2 Diabetes |
Sanofi |
2008-01 | PHASE4 |
| NCT00356486 | COMPLETED | HIV Infections |
Germans Trias i Pujol Hospital |
2005-10 | PHASE4 |
| NCT00774800 | COMPLETED | Type 1 Diabetes Mellitus |
Halozyme Therapeutics |
2008-10 | PHASE2 |
| NCT00629304 | COMPLETED | Type 1 Diabetes |
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète |
2007-09 | PHASE3 |
| NCT00582010 | COMPLETED | Reperfusion Injury; Liver Injury |
University of Alabama at Birmingham |
2008-04 | PHASE2; PHASE3 |
| NCT00314314 | COMPLETED | Bipolar Disorder |
University Health Network, Toronto |
2006-05 | PHASE3 |
| NCT00541372 | COMPLETED | Diabetes Mellitus |
University Medical Center Groningen |
2007-09 | PHASE4 |
| NCT00771004 | COMPLETED | Oxidative Stress; Coronary Artery Disease; Type 2 Diabetes |
Takeda |
2006-08 | PHASE2 |
| NCT01513057 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2009-01 | PHASE1 |
| NCT01477216 | UNKNOWN | Glucose Metabolism |
Finnish Institute for Health and Welfare |
2003-01 | |
| NCT00974051 | COMPLETED | Type 1 Diabetes |
University of Colorado, Denver |
2008-03 | |
| NCT00506662 | TERMINATED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2007-07 | PHASE4 |
| NCT00549614 | COMPLETED | Heart Failure |
University of Aarhus |
2007-10 | |
| NCT00348387 | COMPLETED | Poliomyelitis; Polio |
Sanofi Pasteur, a Sanofi Company |
2006-06 | PHASE3 |
| NCT00668538 | COMPLETED | Healthy |
University of Southern Denmark |
2008-04 | |
| NCT00531999 | COMPLETED | HIV Infections |
St Stephens Aids Trust |
2007-10 | PHASE1 |
| NCT00494078 | COMPLETED | Critical Illness |
Medical University of Vienna |
2006-06 | |
| NCT00699413 | TERMINATED | Obesity; Diabetes Mellitus, Type 2 |
University of Southern California |
2008-02 | PHASE4 |
| NCT00613379 | COMPLETED | HIV Infections |
CytoDyn, Inc. |
2007-12 | PHASE2 |
| NCT00003993 | COMPLETED | Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
National Institute on Aging (NIA) |
1999-09 | PHASE1 |
| NCT00967642 | TERMINATED | Diabetes Mellitus; Percutaneous Coronary Intervention |
Hospital de Clinicas de Porto Alegre |
2006-08 | |
| NCT00808704 | COMPLETED | Hypoxic-Ischemic Encephalopathy |
Zhengzhou University |
2003-08 | PHASE1; PHASE2 |
| NCT00082407 | COMPLETED | Diabetes Mellitus, Type 2 |
AstraZeneca |
2003-11 | PHASE3 |
| NCT00246012 | COMPLETED | Melanoma |
Centocor, Inc. |
2005-05 | PHASE1; PHASE2 |
| NCT00863629 | COMPLETED | Myocardial Infarction; Oxidative Stress; Glycemic Control |
University of Campania Luigi Vanvitelli |
2001-01 | PHASE4 |
| NCT00331604 | TERMINATED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2006-08-31 | PHASE3 |
| NCT00356109 | COMPLETED | Diabetes Mellitus, Type 1 |
Eli Lilly and Company |
2006-08 | PHASE3 |
| NCT00437112 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2007-02 | PHASE3 |
| NCT00585650 | COMPLETED | Psoriasis |
University of California, Irvine |
2007-05 | PHASE1; PHASE2 |
| NCT01996475 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00391209 | COMPLETED | Diabetes Mellitus, Type 2 |
Eli Lilly and Company |
2006-10 | PHASE3 |
| NCT00157339 | COMPLETED | Diabetes Mellitus; Asthma; Pulmonary Disease, Chronic Obstructive |
Eli Lilly and Company |
2005-08 | PHASE3 |
| NCT00328094 | TERMINATED | Peripheral Vascular Disease; Abdominal Aortic Aneurysm |
Beth Israel Deaconess Medical Center |
2006-03 | |
| NCT01159353 | COMPLETED | Type 2 Diabetes Mellitus |
Sanofi |
2007-09 | PHASE1 |
| NCT00100178 | COMPLETED | Diabetes Mellitus, Type 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2004-05 | PHASE2 |
| NCT00618839 | COMPLETED | Third Degree Burn; Burns; Wound Infection; Degloving Injury |
Stratatech, a Mallinckrodt Company |
2006-07 | PHASE1; PHASE2 |
| NCT00467649 | COMPLETED | Type 2 Diabetes Mellitus |
AstraZeneca |
2007-05 | PHASE4 |
| NCT00636038 | COMPLETED | Vitamin A Status |
Tufts University |
2008-01 | PHASE1 |
| NCT00437918 | COMPLETED | Diabetes Mellitus; Type 2 Diabetes Mellitus |
Inje University |
2007-01 | PHASE4 |
| NCT00858897 | COMPLETED | Diabetes Mellitus, Type 1 |
Nemours Children's Clinic |
2007-06 | |
| NCT00718653 | COMPLETED | Eye Health |
National Eye Institute (NEI) |
2004-09 | |
| NCT00657124 | COMPLETED | Liver Disease |
Kochi University |
2007-04 | PHASE4 |
| NCT00260234 | TERMINATED | Diabetes Mellitus, Type 1 |
Novocell |
2005-11 | PHASE1; PHASE2 |
| NCT00954824 | COMPLETED | Metabolic Syndrome X |
University of Pennsylvania |
2003-08 | |
| NCT00479258 | TERMINATED | Diabetes Mellitus, Type 1 |
Pfizer |
2007-10 | PHASE3 |
| NCT00071240 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
2002-10 | PHASE2 |
| NCT01498939 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2007-08 | PHASE1 |
| NCT00438698 | COMPLETED | Type 2 Diabetes; Cardiovascular Disease |
University of Toronto |
2004-09 | |
| NCT00846950 | COMPLETED | Cognition |
Maastricht University Medical Center |
2006-12 | |
| NCT00325130 | COMPLETED | Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis |
Merck Sharp & Dohme LLC |
2006-04 | PHASE3 |
| NCT00274703 | COMPLETED | Oesophagitis, Eosinophilic |
GlaxoSmithKline |
2005-12 | PHASE2 |
| NCT00392457 | COMPLETED | Kallmann Syndrome; Hypogonadism; Gonadal Disorder |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
1995-07 | |
| NCT00859079 | COMPLETED | Diabetes Mellitus Type 2; Hyperglycemia |
Medical University of Graz |
2006-06 | PHASE4 |
| NCT00609856 | COMPLETED | Type 2 Diabetes; Secondary Drug Failure |
Skane University Hospital |
2004-04 | PHASE4 |
| NCT00274274 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2005-09 | PHASE4 |
| NCT01160991 | COMPLETED | Schizophrenia; Diabetes; Insulin Resistance |
Central Institute of Mental Health, Mannheim |
2004-05 | |
| NCT00272012 | COMPLETED | Diabetes Mellitus Type 2 |
Sanofi |
2004-07 | PHASE3 |
| NCT01267396 | COMPLETED | Healthy |
Dr. Reddy's Laboratories Limited |
2006-09 | PHASE1 |
| NCT01486901 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2006-05 | PHASE1 |
| NCT01687556 | COMPLETED | Acne Vulgaris |
Seoul National University Hospital |
2005-07 | |
| NCT00097071 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2004-10 | PHASE3 |
| NCT00569452 | COMPLETED | Diabetes Mellitus Type 1 |
Hoffmann-La Roche |
2006-01 | |
| NCT00494988 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2004-12 | PHASE4 |
| NCT00206934 | COMPLETED | Healthy Volunteers |
University of Copenhagen |
2005-03 | |
| NCT00287456 | WITHDRAWN | Cystic Fibrosis Related Diabetes |
University of Texas Southwestern Medical Center |
2006-02-02 | |
| NCT01498926 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2005-11 | PHASE1 |
| NCT00258804 | COMPLETED | Diabetes Mellitus, Type 2 |
Sanofi |
2005-05 | PHASE4 |
| NCT01497587 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2005-08 | PHASE1 |
| NCT00097084 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2004-09 | PHASE3 |
| NCT00184639 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2004-08-16 | PHASE3 |
| NCT00331279 | COMPLETED | Polycystic Ovary Syndrome |
Columbia University |
2005-08 | PHASE1 |
| NCT00079898 | COMPLETED | Healthy |
National Center for Complementary and Integrative Health (NCCIH) |
2002-07 | |
| NCT02090933 | COMPLETED | No Evidence of Disease |
National Cancer Institute (NCI) |
2004-03 | PHASE2 |
| NCT00612599 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2003-09 | PHASE3 |
| NCT00654121 | COMPLETED | Diabetes, Type I |
Universitair Ziekenhuis Brussel |
2000-02 | PHASE2 |
| NCT01494493 | TERMINATED | Degenerative Disc Disease |
Medtronic Spinal and Biologics |
2000-09 | |
| NCT00569400 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
2003-05-01 | PHASE3 |
| NCT00778583 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2003-09 | |
| NCT00853190 | COMPLETED | Healthy |
Mallinckrodt |
2003-09 | PHASE1 |
| NCT00540709 | COMPLETED | Diabetes Mellitus |
Sanofi |
2002-11 | PHASE4 |
| NCT01649570 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2002-03 | PHASE4 |
| NCT01704378 | COMPLETED | Diabetes; Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2001-04-18 | PHASE4 |
| NCT01448070 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2002-10-15 | PHASE1 |
| NCT00775827 | COMPLETED | Healthy |
Ranbaxy Laboratories Limited |
2002-11 | |
| NCT01698697 | COMPLETED | Diabetes; Healthy |
Novo Nordisk A/S |
2002-09-02 | PHASE1 |
| NCT01707134 | COMPLETED | Diabetes; Diabetes Mellitus, Type 1 |
Novo Nordisk A/S |
1997-09 | PHASE3 |
| NCT01706211 | COMPLETED | Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy |
National Taiwan University Hospital |
1998-10 | PHASE3 |
| NCT00001309 | COMPLETED | Healthy Volunteers |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1997-01-23 | PHASE1 |
| NCT00282594 | COMPLETED | Sepsis; Respiratory Failure; Renal Failure; Surgical Site Infection |
Genesys |
2003-07 | |
| NCT00576784 | COMPLETED | Type 2 Diabetes Mellitus; Insulin Resistance |
IKFE Institute for Clinical Research and Development |
2005-04 | PHASE4 |
| NCT00132106 | UNKNOWN | Heart Failure, Congestive |
Radboud University Medical Center |
2005-08 | |
| NCT00546442 | COMPLETED | Chronic Hepatitis C |
Valme University Hospital |
2006-05 | PHASE4 |
| NCT00507364 | UNKNOWN | Biological Therapy for Chronic Anal Fissure; Treatment by Biological Factors - Activated Macrophages; Interventional Study |
Hadassah Medical Organization |
PHASE3 | |
| NCT00264251 | COMPLETED | HIV Infections; Insulin Resistance; Obesity |
St. Luke's-Roosevelt Hospital Center |
2005-07 | |
| NCT00139763 | COMPLETED | Diabetes Mellitus, Type 2 |
Pfizer |
2005-07 | PHASE3 |
| NCT00143338 | COMPLETED | Diabetes Mellitus, Type 2 |
Pfizer |
2004-11 | PHASE2 |
| NCT00000684 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
||
| NCT01218711 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00004419 | COMPLETED | Insulin Resistance; Hyperglycemia |
Beth Israel Deaconess Medical Center |
1998-04 | |
| NCT00459940 | COMPLETED | Growth Hormone Deficiency |
University of Aarhus |
2004-09 | |
| NCT00297960 | COMPLETED | Healthy Male Volunteers |
Medical University of Vienna |
2005-04 | PHASE4 |
| NCT00137891 | COMPLETED | Healthy |
Genzyme, a Sanofi Company |
2005-06 | PHASE1 |
| NCT00149331 | COMPLETED | Type 2 Diabetes |
Hamilton Health Sciences Corporation |
2005-07 | PHASE4 |
| NCT00034255 | COMPLETED | Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
GMP Endotherapeutics |
2001-12 | PHASE1; PHASE2 |
| NCT00124826 | COMPLETED | Acute Stroke; Hyperglycemia |
University of Glasgow |
2004-05 | PHASE2 |
| NCT00021580 | UNKNOWN | Diabetes Mellitus |
National Center for Research Resources (NCRR) |
PHASE1 | |
| NCT01084486 | COMPLETED | Nonalcoholic Fatty Liver Disease |
Wolfson Medical Center |
PHASE1; PHASE2 | |
| NCT00001870 | COMPLETED | Diabetes Mellitus, Non-Insulin Dependent; Non-Insulin Dependent |
National Center for Complementary and Integrative Health (NCCIH) |
1999-01 | PHASE2 |
| NCT00000683 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00135941 | COMPLETED | Diabetes Mellitus |
Sanofi |
2005-08 | PHASE3 |
| NCT00410852 | COMPLETED | Intensive Care |
Hospital Israelita Albert Einstein |
2005-05 | |
| NCT00000845 | COMPLETED | HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT01418586 | COMPLETED | Healthy |
Torrent Pharmaceuticals Limited |
PHASE1 | |
| NCT00140374 | COMPLETED | Prostate Cancer |
Cell Genesys |
1998-12 | PHASE1; PHASE2 |
| NCT00004401 | COMPLETED | Infant Botulism; Botulism |
California Department of Health Services |
1998-01 | |
| NCT00155935 | UNKNOWN | Ovarian Cancer |
National Taiwan University Hospital |
2004-01 | |
| NCT01114061 | SUSPENDED | Diabetes |
Insuline Medical Ltd. |
(data from https://clinicaltrials.gov, updated on 2026-01-06)
Check the
Insulin (human)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.